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ABSTRACT 
Background: Many avoidable triggers lead to uncontrolled asthma and subsequent Emergency 
Department (ED) visits. The aim of this study was to determine the severity of and potential 
associated triggers for acute asthma attack in patients presenting to the ED of the Bertha Gxowa 
Hospital (BGH). 
Methods: Prospective cross-sectional study. Data from 239 patients managed between February 
2015 and April 2015 was collected through a survey questionnaire and analysed. The Chi-square 
test or Fisher Exact Test was used to test the associations between variables and acute asthma 
severity. Bivariate logistic regression was used to ascertain factors and/or triggers associated 
with acute asthma attack. P-values < 0.05 were considered statistically significant. 
Results: Overall, 239 patients were enrolled (139 males, 100 females, and median age 31 years). 
The majority of them had moderate acute asthma attack (52.72%). Active cigarette smoking (p < 
0.001) and/or passive cigarette smoking (p = 0.004) were identified to be potential associated 
triggers for acute asthma attack. Low level of education (p < 0.001) was identified to be 
significant factor associated with acute asthma attack. There was no significant association 
between acute asthma attack severity and age (p = 0.592), gender (p = 0.240), race (p = 0.759), 
occupation status (p = 0.291), employment status (p = 0.268), type of housing (p = 0.982), acute 
respiratory infection (p = 0.818), use of medication-related asthma triggers (p = 0.942), 
knowledge of asthma allergens (p = 0.086), and stress or anxiety (p = 0.475). 
Conclusion: The study shows that the majority of patients presented with moderate acute asthma 
attack at the BGH ED. Active and/or passive cigarette smoking is a potential associated trigger 
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for acute asthma attack. In addition, this study shows that low level of education is a significant 
factor associated with acute asthma attack. 
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DEFINITION OF TERMS1 
Acute asthma attack: A state of acute airway obstruction and bronchospasm in asthmatic 
patients manifested by expiratory wheezing, shortness of breath or chest tightness, and cough.  
Acute respiratory infection: Non-specific term used to describe respiratory tract infection 
(upper and/ or lower) that affects an individual for less than two weeks’ duration. 
Asthma exacerbation: is synonymous with acute asthma attack, and both terms are used 
interchangeably in this report. 
Asthma trigger: A factor that may exacerbate asthma, or a stimulus which causes an increase in 
asthma symptoms due to airway limitation or obstruction, such as dust mites, cockroaches, 
pollens, respiratory viruses, smoke, and medication-related asthma trigger. They are directly 
implicated in the pathogenesis and/or pathophysiology of asthma. 
Beta-adrenergic blocking agents: A class of drugs that competes with beta-adrenergic agonists 
for available receptor sites: some compete for both β1 and β2 receptors, whereas others are 
primarily either β1 or β2 blockers; used in the treatment of a variety of cardiovascular diseases 
and related conditions, for which beta-adrenergic blockage is desirable. 
Bronchospasm: An excessive and prolonged involuntary contraction of the smooth muscle of 
the bronchi and bronchioles, resulting in an acute functional narrowing and obstruction of the 
respiratory airway. 
Corticosteroids: Group of natural and synthetic analogues of the hormones secreted by the 
hypothalamic-anterior pituitary-adrenocortical axis or pituitary gland, including glucocorticoids, 
which have potent anti-inflammatory properties. 
Employment status: A status of a person in employment as an employee. 
Factor associated with asthma exacerbation: A non-specific term used to describe any 
variables that may be associated with an increase in the incidence of asthma exacerbation, either 
by being directly implicated (triggers), or not (factors) in the pathogenesis and/or 
pathophysiology of asthma. Examples of these factors are age, gender, race, and occupation 
status, level of education, and stress or anxiety. 
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Forced expiratory volume in first second: The maximum volume of air expired from the lung 
in one second when starting from maximum inspiration. 
Forced vital capacity: The volume of air exhaled with maximum effort and speed after a full 
inspiration. 
Hypoxaemia: Lower than normal oxygen tension in the arterial blood inducing a lower than 
normal saturation of haemoglobin and oxygen content per unit volume. 
Hypoxia: Reduction of oxygen supply to a tissue below physiological levels without or not a 
good perfusion of the tissue by blood. 
Inflammation: A fundamental pathological process consisting of a dynamic of histological 
apparent cytologic changes, cellular infiltration, and mediator release that occurs in the affected 
blood vessels and adjacent tissues in response to an injury or abnormal stimulation caused by a 
chemical or biologic agent. 
Lower respiratory tract infection: Nonspecific term used to describe acute infections involving 
bronchi, bronchioles, trachea, alveoli and lung tissues. 
Non-steroidal anti-inflammatory drugs: Group of anti-inflammation and analgesic drugs, 
including Diclofenac, Aspirin, Ibuprofen, Meloxicam, Ketorolac, and Mefenamic acid, which act 
by inhibiting the cyclooxygenase pathway and preventing the release of potent inflammatory 
mediators (i.e. Prostaglandins, Leucotrienes, and Thromboxanes). They are used for acute and/or 
chronic pain and inflammation. 
Occupation status: A status of a person having a money-generating activity, including self-
employment.  
Oedema: Accumulation of an excessive amount of watery fluid in cells, tissue, or serous 
cavities. 
Passive cigarette smoking: Cigarettes smoked by patient’s household (in the context of this 
study). 
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Peak expiratory flow (PEF): The greatest rate of airflow that can be achieved during forced 
expiration, beginning with the lungs fully inflated. 
Statistical power: Ability to find a difference that truly exists or probability of correctly 
rejecting the null hypothesis when it is false; related to number of patients or size of difference 
sought. This avoids Type II error or error of failing to observe a difference when in truth there is 
one. 
Uncontrolled asthma: is defined in the presence of ≥ 3 features of partly controlled asthma 
(daytime symptoms more than twice a week, any limitation of activity, any nocturnal 
symptoms/awakening, need for reliever medication more than twice a week, PEF < 80% 
predicted or personal best, and  ≥ 1 exacerbation per year), or an exacerbation in any week.2 
Upper respiratory tract infection: A nonspecific term used to describe acute infections 
involving the nose, paranasal sinuses, tonsils, pharynx, and larynx. 
Ventilation: The movement of air (oxygen) between the environment and the lungs by 
inhalation and exhalation. 
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CHAPTER 1 
INTRODUCTION 
1.1. Background information 
Asthma is a major public health problem worldwide, generates significant healthcare costs 
and has high morbidity and mortality rates.3 The World Health Organization (WHO) 
estimated that between 100 and 150 million people worldwide suffer from asthma, and over 
180 000 deaths occur annually.4 In the United States of America (USA), it is estimated that 
approximately 18.7 million adults (8.2%) had asthma according to 2010 data from the experts 
of the Centers for Disease Control and Prevention (CDC).5 The Republic of South Africa 
(RSA), with 8.1% prevalence over all ages, ranked 25th worldwide, and the asthma case 
fatality rate in the country is reported as being the fourth highest in the world, with 1.5% 
deaths annually.6,7 Recently, it has been documented that South Africa has the highest 
prevalence of asthma in Africa.8 Adeloye et al. conducted a systematic review to ascertain an 
estimate prevalence of asthma in Africa in which they included 45 studies covering most 
parts of Africa (South Africa: 11 studies, Nigeria: 8 studies, Ethiopia: 6 studies, Kenya: 5 
studies, and 4 studies in each in Algeria, Morocco and Tunisia). They found that cumulative 
prevalence of asthma was highest in South Africa.8 Asthma morbidity and mortality are 
potentially preventable with optimal control of chronic asthma and appropriate management 
of acute exacerbation.9  
 
Asthma is a chronic inflammatory disease of the airways which is usually allergic in origin, 
characterized by a markedly variable degree of reversibility of airflow obstruction and 
bronchospasm.9,10 A wide range of stimuli in addition to genetic predisposing factors readily 
induce a state of airway hyperresponsiveness in asthmatic patients.9,10 This is a result of an 
excessive bronchoconstrictor response to multiple inhaler triggers that would have no effect 
on a normal airway.10 The pathophysiology of acute asthma consists of bronchoconstriction, 
inflammation, and mucus impaction.5,10 These result from the release in the systemic 
circulation of a variety of cell types, including mast cells, eosinophils, lymphocytes, 
macrophages, and neutrophils.5,10  
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These cells release a number of potent inflammatory mediators, including Prostaglandins, 
Leucotrienes and Thromboxanes, which interact in complex ways to induce a chronic state of 
airway inflammation in both the mucosal and muscle layers of the airways.10 This ultimately 
leads in the former to epithelial cell desquamation, mucus hypersecretion and mucosal 
oedema, and in the latter to smooth muscle hypertrophy, hyperplasia, and contraction or 
bronchospasm.5,10 These in turn will lead to a reduction in forced expiratory volume in first 
second (FEV1), FEV1/forced vital capacity (FVC) ratio, and PEF, and as well as an increase 
in airway resistance.10 There is also evidence of reduction of ventilation and increased 
pulmonary blood flow, resulting in a mismatch of ventilation and perfusion, thus further 
inducing hypoxaemia.2,10  
 
The diagnosis of asthma is based primarily in the history of young age of onset, family 
history of asthma, the presence of atopy, identification of asthma triggers and common 
symptoms, which include wheezing, shortness of breath or chest tightness, and coughing.5,9,10 
Spirometric lung function tests are useful in the diagnosis, assessment of severity and 
management of asthma.9 The commonest diagnostic abnormality is a reduction in FEV1 and 
PEF, and the ratio to FEV1 to FVC to below 70% is characteristic of obstructive airways 
disease.9,10 A significant reversibility of the airway obstruction is the hallmark of bronchial 
asthma, which is defined as the presence of an increase in FEV1 of > 12% and 200 ml, 15 to 
30 minutes following the inhalation of 200 to 400 microgram of a short-acting bronchodilator 
(i.e. Salbutamol), or a 20% improvement in PEF from baseline.9,10 
 
Its treatment goals are to relieve hypoxaemia and airflow limitation or obstruction as urgently 
as possible, and provide a suitable plan to control the disease and avoid relapse.5,9 These  
require urgent and aggressive treatment with simultaneous administration of oxygen, inhaler 
bronchodilators, including Beta-2-agonists and Ipratropium bromide, and Corticosteroids.5 
Intravenous magnesium sulphate provides additional benefits in the case of severe acute 
asthma refractory to previous treatment.5,9 Intubation may be indicated for impending acute 
respiratory failure unresponsive to the previously described treatment.5 Triggers leading to 
acute asthma attack should be identified and preventable measures implemented to prevent 
acute attacks.9 
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1.2. Rationale of the study 
There are many avoidable triggers leading to uncontrolled asthma and subsequent Emergency 
Department (ED) visits,10-12 and acute asthma attack is preventable with optimal control of 
these triggers.10-12 This conclusion had been reported in many studies.11,12 Examples include 
the cross-sectional study of factors associated with patient visits to the ED in Saudi Arabia by 
Al-Jahdali et al.,11 and the cross-sectional study of triggers in adult asthma by Goksel et al. in 
Turkey.13  
In the course of working at Bertha Gxowa Hospital (BGH) the researcher noticed that many 
patients presenting to the ED with acute asthma attack had uncontrolled asthma and low 
income. Most of them were also smokers, unemployed or uneducated, and were not educated 
about asthma triggers. Finally, they had not consistently made follow-up visits to clinics or to 
private doctors. The Working Group of South African Thoracic Society (WGSATS) 2013 
guidelines assert that in order to optimize patient care the avoidable triggers for acute asthma 
attack should be reviewed or provided to all asthmatic patients prior to their being discharged 
from the hospital.9 The importance of this was confirmed by Gibson et al. in their meta-
analysis of 26 randomized controlled trials (RCTs).12 
To the best of the researcher’s knowledge, there are very few published South African studies 
that have investigated the triggers for acute asthma attack in South Africa. An online 
literature research yielded these two examples: the study of the magnitude of the asthma 
problem in Cape Town by Westerman et al. and the case-control study of severe life-
threatening asthma (SLTA) by Van der Merwe et al.14,15 The two studies were conducted in 
tertiary hospitals in Cape Town in 1978, and between 1997 and 2000, respectively. The 
former included mainly the white population, as this was during the apartheid period.14 The 
latter focused on patients with imminent respiratory arrest asthma admitted to the intensive 
care unit (ICU) and asthmatic patients attending outpatient respiratory clinic.15  
There are no recent South African studies that have attempted to determine the severity and 
associated triggers for acute asthma attack in the ED. Therefore, the purpose of this study was 
to determine the severity of and associated triggers for acute asthma attack at the BGH ED. 
This study has relevance to Family Medicine, as asthma has a significant morbidity and 
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mortality, especially in South Africa, a developing country with a developing primary 
healthcare (PHC) system facing resource constraints.2,7,9 
The researcher hopes that the recommendations made from the findings of this study to the 
management of the BGH will result in lower asthma presentation rates in the hospital ED. 
This will ultimately curb the expenditure associated with asthma care. This information will 
also be useful to policy makers and facility managers nationally, especially at the PHC level, 
in saving cost, optimizing patient care and improving healthcare services. 
 
1.3. Organizational report 
The research report has five central chapters. Chapter 2 is a literature review, Chapter 3 deals 
with materials and methods, Chapter 4 covers results, Chapter 5 is discussion, and Chapter 6 
contains conclusions and recommendations. These chapters are followed by appendices and 
references. The next chapter reviews the literature relevant to the study. 
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CHAPTER 2  
LITERATURE REVIEW 
The researcher searched Pubmed, Cochrane Library, SUM Search 2, TRIP Database, 
Essential Evidence Plus, Up to date and Google Scholar for studies in relation to his research 
question. Relevant studies were selected for review and the information obtained is presented. 
It includes the proportion of patients presenting with acute asthma attack in an ED, severity 
assessment and factors and/or triggers associated with acute asthma attack presentation. 
2.1. Proportion of patients presenting with acute asthma attack to an 
Emergency Department 
Many studies indicate that acute asthma attack is a common medical emergency, with 
significant numbers of ED visits and subsequent hospital admissions and deaths.16,17,18 Higher 
proportions of acute asthma attack in ED have been reported in many international 
studies.16,17,19 For example, in the USA, acute asthma attack represents the 11th most frequent 
ED diagnosis.16 In their review of acute asthma in adults, Rodrigo et al. documented a 
proportion of 20%.17 Watase et al. in Japan also reported a proportion of 47%.19 Surprisingly, 
lower proportions of acute asthma attack in ED have been reported in developing countries 
compared to that of the developed countries.18 The study by Kirenga et al. of asthma and 
patterns of asthma medication prescriptions among adult patients conducted in ED and the 
respiratory clinic of a tertiary healthcare facility in Uganda found a proportion of 2.5%.18 In 
addition, the authors of this study documented a proportion of 16.9% of acute asthma attack 
in the respiratory clinic of the same hospital where the study was conducted.18  
 
In the RSA there are few published studies investigating the proportion of patients presenting 
with acute asthma attack in ED. One study, by Westerman et al., of the magnitude of the 
asthma problem at Groote Schuur Hospital, in Cape Town, has shown that acute asthma 
attack represents 10% of all patients seen in the ED.14 This data indicates that, overall, acute 
asthma attack accounts for a significant number of ED visits worldwide, including in South 
Africa. 
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2.2. Severity assessment of acute asthma attack 
Many studies have demonstrated that there is a poor correlation between clinical judgment 
and lung function, and patients and healthcare providers (HCP) both underestimate acute 
asthma severity.5,9 The use of clinical symptoms and signs together with lung function 
measures and laboratory parameters may overcome these difficulties by reproducing an 
accurate judgment of the degree of airflow limitation.9 This principle has been used in the 
development of the two guidelines described below: 
The revised British Thoracic Society (BTS) guidelines published in October 2014 classified 
acute asthma attack as mild, moderate, severe, life-threatening and near-fatal acute asthma 
attack.20 Acute moderate asthma attack includes increasing asthma symptoms, PEF > 50-70% 
and no features of acute severe asthma attack. Acute severe asthma attack is defined in one 
of: PEF 33-50% best or predicted, respiratory rate (RR) ≥ 25 breaths/min, heart rate (HR) ≥ 
110 beats/min and inability to complete sentences in one breath. Life-threatening acute 
asthma includes any of: PEF < 33% best or predicted, oxygen saturation (SO2) on room air < 
92%, partial pressure arterial oxygen  (PaO2) < 8 kpa, normal partial pressure arterial carbon 
dioxide (PaCO2) which is within 4.6 and 6.0 kpa, silent chest, cyanosis, poor respiratory 
effort, arrhythmia, exhaustion or altered consciousness level and hypotension. Near-fatal 
acute asthma attack is documented in the presence of raised PaCo2 and/ or requiring 
mechanical ventilation with raised inflation pressure.20 Patients with asthma exacerbations 
without the above-mentioned criteria are classified as having mild acute asthma attack.20 
The WGSATS published their guidelines in March 2013, which conveniently classified acute 
asthma attack as mild, moderate, severe, and imminent respiratory arrest attack based on 
symptoms, signs, lung function and laboratory parameters (Appendix A).9 In this later 
guideline it has been recommended that the presence of several parameters, but not necessary 
all, indicates the general classification of the exacerbation.9 This is practical in ED, as most 
patients with asthma exacerbation do not require laboratory studies,5 especially for the South 
African population given the resource constraints the healthcare system in South Africa 
faces.9   
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Regarding the proportions of mild, moderate and severe acute asthma attack in ED, studies 
have reported different findings.21,22,23 Dankner et al. in Israel found that the majority of 
patients (37.9%) had moderate acute asthma attack.21 In this study the authors assessed the 
severity of asthma exacerbation through a simplified scoring system for asthma exacerbation 
in ED.21 This scoring system is based solely on vital signs, readily available symptoms and 
signs, including pulse rate, wheezes, rales or prolonged expirium, oxygen saturation on room 
air, and the use of accessory muscles of respiration, measured upon arrival of patients in 
ED.21 However, this conclusion was in contrast with the findings of Refaat et al. in their 
prospective study of acute asthma in ED, prevalence of respiratory and non-respiratory 
symptoms, in Egypt, in which they found a large proportion of patients (52.6%) had severe 
acute asthma attack.22 Sanya et al. in Uganda also reported a higher proportion (55%) of 
severe acute asthma attack.23  
 
2.3. Triggers and /or factors associated with acute asthma attack  
Many triggers have been reported to cause patients with a poor asthma control status to 
increasingly frequent EDs.9 These triggers include active and/or passive cigarette smoking, 
acute respiratory infection, asthma allergens, and medication-related asthma trigger (non-
steroid anti-inflammatory drugs (NSAIDs) and Beta-blockers).9,13 There are also many 
factors that have been reported to be associated with acute asthma attack presentation.6,9,13 
These factors include demographic factors (age, gender, race), social factors (employment or 
occupation status, low income, low education level, and non-urban type of housing), clinical 
factors (not being educated about asthma allergens and non-adherence to asthma treatment), 
and psychological factor (stress and anxiety).6,9,13 Asthma triggers can induce a functional 
state of airway narrowing and bronchospasm with subsequent wheezing and dyspnoea or 
chest tightness in asthmatic patients.6,10  
 
Most experts have agreed that reducing the need for the use of ED for acute asthma attack 
treatment remains an important goal of the overall management of the disease, as acute 
asthma ED care is substantial.16,17 The importance of this has been demonstrated by Weis et 
al. in their study of an economic evaluation of asthma in the USA, in which they 
demonstrated that the utilization of the ED for asthma management accounted for almost one-
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third of all asthma costs.24 Thus, asthma triggers need to be well explored and identified in 
order to optimize health care and minimize the cost related to asthma care.  
2.3.1. Demographic factors 
Many demographic factors are reported to be associated with acute asthma attack 
presentation. These factors include age, gender, and race. 
 
2.3.1.1. Age 
The evidence indicates that acute asthma attack and related deaths have been significantly 
associated with age.15,24,25 A USA study demonstrated that the number of acute asthma 
presentations and related deaths increase with age.24 In their study of risk factors for 
hospitalization among adults with asthma and the influence of socio-demographic factors and 
asthma severity, Eisner et al. found that age (increases by ten years) was a significant factor 
associated with acute asthma severity and/or hospitalization.25 This conclusion have been 
reported in many other studies.15,26 Examples include the study by Van der Merwe et al. in 
Cape Town and the study by Bavbek et al. in Turkey.15,26 However, Fernandes et al. in Brazil 
found non-significant association between age and asthma exacerbation.27 
 
2.3.1.2. Gender 
The female gender has been reported to be associated with severe acute asthma attack.28,29 In 
their study of the gender dimension of asthma, in the USA, Kynyk et al. found that women 
are more likely to have severe acute asthma and suffer greater morbidity than men (p < 
0.05).28 This conclusion was also reported by Eisner et al. in USA25 and by Lkeue et al. in 
Japan.29 However, other studies have found that male gender is a significant factor associated 
with acute asthma attack.27 In their study of risk factors for death in patients with severe 
asthma, Fernandes et al. found a significant association between male gender and severe 
acute asthma attack and/ or death (p < 0.001).27  
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2.3.1.3. Race 
Evidence has shown that being a member of a non-white race, especially black, is a 
significant factor associated with acute asthma severity.15,25,30 In their prospective cohort 
study of the role of race/ethnicity and socioeconomic status of acute asthma among adults 
presenting to the ED in USA, Boudreaux et al. found significant racial/ethnicity differences 
in the sense that there were more black than white patients with severe acute asthma attack (p 
< 0.001).30 Eisner et al. also in USA found that being a member of a non-white race 
(Hispanic) was associated with severe asthma exacerbation and/or hospitalization (OR 3.1, 
95% CI: 1.1 to 8.8).25  
 
2.3.2. Social factors and/or triggers 
Many social factors have been shown to be associated with acute asthma attack as they have a 
potential impact on asthmatics’ quality of life, adherence to asthma treatment, and chronic 
asthma control.12,24 These factors include having a low income, living in rural type of housing 
(informal settlement (IS), reconstruction development programme (RDP), and squatter camp 
(SC)), and having a lower level of education.12,15,24,31 There is another social factor (active 
and/or passive cigarette smoking) capable of inducing asthma exacerbation. Thus, it is 
considered an asthma trigger.10 
 
2.3.2.1. Occupation or employment status 
Studies have demonstrated that not having an income-generating occupation or being 
unemployed is a significant factor associated with severe acute asthma attack.15 The study by 
Van der Merwe in Cape Town found that lack of formal employment was significantly 
associated with severe life-threatening asthma (p = 0.002).15 With regard to this conclusion, 
an important factor to be taken into account is that the study was conducted only in a public 
health institution (Tygerberg Academic Hospital), which could be acknowledged as one of 
the study limitations by the inverstigators.15 However, many international studies, for 
example, those by Fernandes et al. in Brazil and by Schwenkglenks et al. in Swaziland, have 
also pointed in the same direction in the sense that lack of income-generating occupation was 
a significant factor associated with asthma exacerbation.27,32  
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2.3.2.2. Low income 
Low income is also considered as significant factor associated with severe acute asthma 
attack.25 There are several possible explanations for this. Firstly, low income may induce 
higher level of stress in asthmatic individuals.10 Secondly, for private patients or countries 
where medical care is paid by patients themselves, the provision of asthma treatment is costly 
and needs to be afforded by asthmatic individuals.10 Failure to secure this will ultimately 
occasion non-adherence to asthma treatment and subsequent asthma exacerbations.4,10 
Thirdly, low income is documented as being a greater barrier for specialized medical care, 
especially for private patients.15 Lastly, low income may be a marker for other exacerbating 
factors, such as cockroach antigen exposure, cigarette smoking, and secondhand smoke 
exposures.25 The study by Eisner et al. described above found that lower household income 
was significantly associated with greater risk of hospitalization (OR 1.1, 95% CI: 0.9 to 
1.3).25 Van der Merwe et al. in Cape Town also found that no formal income in an individual 
was a significant factor associated with severe life-threatening asthma (p = 0.002).15  
 
2.3.2.3. Education level 
Low level of education had been reported to be significant factor associated with acute 
asthma attack presentation.12 Studies have shown that lower level of education has negative 
outcomes in asthmatic patients as it increases poor disease control and asthma-related ED 
visits with subsequent asthma morbidity and mortality. In their study of risk factors for 
emergency room visits due to asthma exacerbations in Brazil, Brandao et al. documented that 
having a low level of education was significantly associated with asthma exacerbation (OR 
1.53, 95%CI: 1 to 2.39).33 Bavbek et al. in Turkey also found a statistically significant 
difference between low education level and asthma exacerbation (p < 0.05).26  
 
2.3.2.4. Type of housing 
Certain specific types of housing is significant factor associated with acute asthma attack.15 
The study by Van der Merwe et al. in Cape Town described above found that a rural type of 
housing (IS, RDP, and SC) was a significant factor associated with severe life-threatening 
asthma (p = 000.5).15 Surprisingly, this conclusion was previously reported even in developed 
countries, such as United Kingdom (UK) and Australia.34,35 This type of housing is mainly 
found in rural areas where access to specialized medical care is limited, which in turn could 
lead to sub-optimal asthma management, especially in severe asthma exacerbation.15,35 Also, 
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a rural type of housing may be a marker for other asthma-exacerbating triggers, such as 
cockroach antigen exposure, dust at home, and secondhand smoke exposure.25 
2.3.2.5. Active and passive cigarette smoking 
Cigarette smoking considerably increases the risk episodes of breathing difficulty due to 
asthma in addition to cigarette smoke-induced fast decline in lung function and lung diseases, 
including chronic bronchitis, emphysema, chronic obstructive pulmonary disease (COPD) 
and lung cancer.4 Also, there is evidence that cigarette smoking interferes with the anti-
inflammatory actions of corticosteroids, necessitating higher doses for asthma control, or 
leading to detrimental effects in effectiveness of steroid therapy.10,36 Cigarette smoking cause 
airway irritation, and increases its responsiveness and sensitization to several allergens, and 
precipitate acute episodes of asthma.10 The literature has also indicated the negative effects of 
active and/or passive cigarette smoking in the sense that it significantly induces entire airway 
destruction, leading to higher asthma-related complications, with subsequent morbidity and 
mortality.4,10 Diaz-Sanchez et al. in their randomized, placebo-controlled crossover study, 
have proven the negative effects of cigarette smoke in asthmatic individuals.37 Thus, active 
and/or passive cigarette smoking has been strongly reported as being one of the potential 
triggers of acute asthma attack.5,10   
 
The study by Lkeue et al. found that cigarette-smoking was common among patients with 
acute asthma, and the current-smoker status was significantly associated with frequent ED 
visits and severe acute asthma attack (p < 0.05).29 Westerman et al. also arrived at the same 
conclusion.14 However, this conclusion was not in line with the findings of other studies.38 
The study by Patel et al. found that one-third of ED patients with acute asthma smoked 
cigarettes, although there was no significant association between cigarette smoking and acute 
asthma exacerbation.38 The number of cigarettes smoked per day has also been reported as 
being a significant exacerbating asthma factor. Morkjaroenpong et al. in the USA, Thomson 
et al. in the UK, and Jindal et al. in India have documented statistically significant 
associations between numbers of cigarettes smoked per day and asthma exacerbation.39,40,41 
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2.3.3. Clinical factors 
2.3.3.1. Acute respiratory infection 
Upper respiratory tract infection (URTI) is a potential trigger associated with acute asthma 
attack.42,43,44 In a case-control study of viral and bacterial infection in acute asthma and 
COPD that increases the risk of readmission in Australia, Wark et al. found that URTIs are 
important determinants of more severe exacerbation of asthma.42 Upper respiratory tract virus 
such as Rhinovirus, Respiratory syncytial virus, and Coronavirus are the most commonly 
reported viruses in the pathogenesis of asthma exacerbation.10 They have the potential to 
invade the epithelial cells of both upper and lower airways and increase the airway 
inflammation with a significant number of eosinophils and neutrophils.10 There is also 
evidence of the reduction of type I Interferons production by epithelial cells from asthmatic 
patients, leading to increased susceptibility to these viral infections and significant 
inflammatory response of the entire airway.10  
Nicholson et al. used culture and serological methods of extreme sensitivity (RT-polymerase 
chain reaction assays) in detecting respiratory viruses.45 In their longitudinal study of 138 
adults with asthma, nose and throat swabs and blood samples were collected to coincide with 
symptoms of URTI or severity of asthma exacerbation.45 They found 25% of confirmed viral 
infections were associated with a mean PEF of 50 l/min or more and 15% were associated 
with a PEF of 25 l/min or more.45 In addition, Nicholson et al. found that respiratory viruses 
were implicated in 50% of all severe acute asthma attacks, which were defined as decreased 
PEF to equal or below 50 l/min.45 In their multivariate analysis, Sanya et al. found that URTI 
was a significant trigger associated with acute asthma attack (OR  4.516, 95%CI: 1.258 to 
16.213; p = 0.018).23 
2.3.3.2. Medication-related asthma triggers 
Some medications, namely Beta-adrenergic blockers and NSAIDs, have been shown to 
trigger asthma exacerbation.5,10 These medications are involved in the pathophysiology of 
asthma, as they induce bronchoconstriction by different intracellular pathways.5,10 The 
mechanisms of which Beta-adrenergic blockers induced asthma exacerbation are not clear, 
but are likely mediated through increased cholinergic bronchoconstriction.7 The mechanisms 
by which NSAIDs, including Aspirin, induce asthma exacerbation are by inhibiting 
cyclooxygenase enzyme with the immediate effect of releasing potent bronchoconstrictors, 
including prostaglandins and thromboxanes in the systemic circulation.10 Thus, these 
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medications are considered triggers associated with acute severe asthma attack.5,10 The two 
Turkish studies described above, namely by Bavbek et al. and by Goksel et al., found that 
medication-related asthma was a potential associated trigger for asthma exacerbation.13,26  
 
2.3.3.3. Adherence to asthma treatment 
Lack of adherence to asthma treatment results in increasing asthma morbidity and mortality, 
and it is associated with increasing asthma treatment cost.10,31,46,47 The WHO 2003 report 
estimates that asthma treatment adherence rate is often below 50% in developing countries.46 
The chronic course of asthma is often characterized by asymptomatic episodes and/or without 
immediate short-term complications.48 These factors may contribute to making adherence to 
treatment challenging.48 Non-adherence to the recommended treatment plan increases the 
number of asthma attacks and hospitalizations.46,47 In their prospective, observational study 
of current outpatient management of asthma showing poor compliance with international 
consensus guidelines, in Pittsburgh, Taylor et al. found that significant proportions of 
asthmatic patients presenting to the ED (11% for bronchodilators and 89% for 
corticosteroids) did not comply with their treatment recommendation (p < 0.05).47 The study 
by Geyser et al. in Pretoria and by Engelkes et al. in the UK, also found that non-compliance 
was significantly associated with asthma exacerbation (all p < 0.005).49,50    
 
Studies have found different possible explanations for non-adherence to asthma 
treatment.50,51,52,53 Sundberg et al. in Sweden found that anxiety was an independent reason 
for non-adherence to an asthma treatment regimen (OR 2.35, 95%CI: 1.18 to 4.69).51 In their 
review of adolescent treatment compliance in asthma, Dinwiddie et al. documented reasons 
for not adhering to asthma treatment, such as inadequate instructions, a too-complex regimen, 
it being time-consuming, inadequate training in inhaler technique, and a lack of 
understanding of the need for long-term preventive treatment, especially when preventive 
medication does not produce immediate symptom relief.53 
 
2.3.3.4. Knowledge of asthma allergens 
Asthma allergens have been reported as potential triggers associated with acute asthma 
attack.10 Allergens activate mast cells which bind Immunoglobulin (Ig) E directly, leading to 
airway oedema and acute inflammatory response with increased eosinophils and 
neutrophils.10 Rosenstreich et al. in the USA found that asthmatic patients sensitized and 
highly exposed to cockroach allergens were at greater risk of severe asthma exacerbation 
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and/or hospitalization, compared with either the non-exposed or non-sensitized patients.54 
Rosas et al. also documented a significant association between asthma-related ED visits and 
the presence of asthma allergens (p < 0.05).55 In addition to this, the authors of this study 
demonstrated that grass pollen exposure was a significant trigger associated with asthma 
hospitalization in both children and adults, independently to other known asthma allergens (p 
< 0.001).55  
 
A lack of education about allergens has been documented previously as a potential factor 
associated with asthma exacerbation.12,56 In their study of how well asthmatic patients were 
educated about their asthma, Lee et al. concluded that asthmatic patients are not educated 
about their disease, including the role of asthma allergens.56 Interestingly, the authors of this 
study also demonstrated that patients not well educated about asthma allergens had a greater 
chance of having more acute asthma attacks than those who are well educated on asthma 
allergens (p < 0.05).56 The study by Refaat et al. described above found that a significant 
proportion (21.3%) of adult patients with asthma exacerbation were exposed to allergens.22 
Thus, educating asthmatic patients on asthma allergens may potentially decrease the higher 
rates of asthma exacerbations documented worldwide.57-59,60-62, 63-68,69 
 
2.3.4. Psychological factor 
2.3.4.1. Stress or anxiety 
Stress or anxiety is a significant factor associated with acute asthma attack.10 Asthma and 
stress or anxiety can mutually potentiate each other through direct psychological mediation or 
cholinergic reflex pathways, non-adherence to medical treatment regimen, inaccurate 
perceptions about asthma symptoms and exposure to asthma triggers.10,51,70 For example, an 
anxious asthmatic individual may became careless in taking his/her medications or in 
consistently making follow-up visits to healthcare facilities.51 This was confirmed by 
Sundberg et al. in Sweden, who found that anxiety (OR 2.35, 95%CI: 1.18 to 4.69) was one 
of the independent reasons for non-adherence to asthma treatment regimens.51 Kolbe et al. in 
New Zealand concluded that anxiety was a considerable factor in psychological morbidity in 
hospitalized patients admitted with acute asthma attack.70 In addition to this, the authors of 
this study demonstrated that stress or anxiety was a significant factor associated with acute 
asthma attack presentation (p < 0.05).70  
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2.4. Summary of the literature review 
The above literature review shows that the proportion of acute asthma attacks in EDs 
worldwide, including South Africa, is significant. Several factors, including demographic, 
social, clinical and psychological, can be significantly associated with acute asthma attack 
presentation. There are also several potential triggers for acute asthma attack, including active 
and/or passive cigarette smoking, asthma allergens, upper respiratory infection, and 
medication-related asthma triggers. 
 
2.5. Study aim 
The aim of the study was to determine the severity of and associated triggers for acute asthma 
attack in patients presenting to the Emergency Department of the Bertha Gxowa Hospital. 
2.6. Study objectives 
1. To determine the proportion of patients presenting with acute asthma attack at the 
Bertha Gxowa Hospital Emergency Department. 
2. To determine the severity of acute asthma attack in patients presenting at the Bertha 
Gxowa Hospital Emergency Department.  
3. To describe the socio-demographic factors pertaining to these patients.  
4. To determine factors and/or triggers associated with acute asthma attack in these 
patients. 
The next chapter describes the materials and methods used in the study. 
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                                               CHAPTER 3  
MATERIALS AND METHODS 
This chapter describes the study methodology employed and the permission granted to 
undertake the study. It includes the study design, site, population, sample size, inclusion and 
exclusion criteria, pilot study, data collection tool and data collection, data analysis, and 
ethical considerations.  
3.1. Study design 
A “cross-sectional study design” is a survey of the frequency of disease, risk factors or other 
characteristics in a defined population at a particular time.71 It is a design used in quantitative 
research, which is based on the measurement and analysis of data collected in numerical 
quantities.71 A prospective study refers to the procedure followed in collecting data by the 
study investigator before any of the study participants have developed any of the outcomes of 
interest.71 Thus defined, this was a prospective cross-sectional study.  
3.2. Study site 
The study was conducted in the ED of the BGH in Germiston, South Africa. The hospital is 
the only district hospital located in Germiston in the southern sub-district of the Ekurhuleni 
Heath District, in Health Region B of Gauteng Province, in South Africa. District hospitals 
form part of the district health system by assuring delivery of comprehensive PHC services.72 
They play a pivotal role in supporting PHC, on the one hand, and being a gateway to more 
specialist care, on the other.72  
As a district hospital, BGH provides level one (generalist) services to in-patients and out-
patients (ideally on referral from community health centres or clinics). It has 258 beds for in-
patient care distributed across four wards (medical, surgical, paediatrics, and obstetrics and 
gynaecology). It also has an out-patient department (OPD), operating theatres, and an ED. Its 
ED has 24-hour services which are run by clinical associates, interns, medical officers, family 
medicine registrars, specialist family physicians, and a specialist emergency physician. BGH 
refers all serious conditions to a level two hospital, Thelle Mogoerane Regional Hospital.  
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BGH also serves as a training site of students for the Faculty of Health Sciences of the 
University of the Witwatersrand. 
 
3.3. Study population 
The study population consisted of patients diagnosed with acute asthma attack, aged 18 years 
or above, presenting at the BGH ED from 01st February 2015, 00h 00 to 30th April 2015, 00h 
00. 
 3.4. Study sample size  
The sample size was calculated using the Raosoft software.73 The records of the BGH 
information system showed that the total number of patients presenting with acute asthma 
attack at the BGH ED was between 180 and 210 per month. As the study was done over a 
three-month period, the total population was approximately 630. Using a 5% margin of error, 
95% confidence interval (CI) and 50% response distribution, the sample size determined was 
239. Consecutive sampling was used. Every patient with acute asthma attack was invited to 
participate voluntarily in the study until the required sample size was reached. 
3.5. Study inclusion criteria 
 All patients aged 18 years or above, managed at BGH ED with acute asthma attack 
 All patients able to perform a PEF for airflow limitation assessment 
 
3.6. Study exclusion criteria 
 Patients unable to speak and understand English 
 All patients who declined to participate in the study 
 
3.7. Pilot study 
A pilot study, comprising a sample of seven participants, was done to test if the questions on 
the study questionnaire were well understood by the participants. This sample was not 
included in the data analysis. There were no major adjustments in the study questionnaire. 
Minor changes were made to the numbering of questions for better data capturing and 
analysis. Also, a few questions were removed from the study questionnaire, as the researcher 
found that they were not contributing much in answering the research question. 
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3.8. Data collection tool 
A study questionnaire (Appendix B) was used. This was written in English. This tool was 
developed by the researcher with the aim of answering the research question. This study 
questionnaire was divided into three parts. The first part determined the socio-demographic 
characteristics of the participants. The second part assessed the severity of acute asthma 
attack in these patients using the WGSATS guidelines (Appendix A).9  
 
The third part included five sections: the first section determined the presence of concomitant 
acute respiratory infection in these patients. The second section determined the presence of 
any prior or concomitant use of certain medication known as triggers associated with asthma 
exacerbation by these patients. The third section assessed the patient’s adherence to his/her 
asthma treatment at home. The fourth section focused on asthma triggers. The “Talking about 
asthma” pamphlet recommended by the South African Department of Health was used. 
Finally, the last section determined other relevant triggers for acute asthma in these patients 
(Appendix B). 
 
3.9. Data collection 
The study proceeded as follows: before commencing the study the researcher explained to 
ED colleagues that he was conducting a study to determine the severity and associated 
triggers for acute asthma attack in patients presenting to the BGH ED, discussed this with 
them in general, and requested them to volunteer to participate in the study (Appendix C). 
The researcher then asked them to assess the patient’s acute asthma attack severity as per 
WGSATS recommendations (Appendix A). This was made available in all ED consulting 
rooms for quick reference. After an eligible patient was managed and stabilized by the ED 
colleagues the researcher interviewed the patient and requested his/her participation in the 
study, following written informed consent (Appendix D). Following this, the researcher 
confirmed that the case fitted the study inclusion criteria and then collected all the required 
study information, including their PEF assessments, as per the study questionnaire (Appendix 
B).   
 
A small proportion of data was collected by the ED colleagues in the absence of the 
researcher in ED, for example after working hours. In this case, before collecting data, the 
ED staff communicated telephonically (using social media networks: WhatsApp and Viber) 
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with the researcher to ascertain his availability in the next few hours. In the majority of cases 
the researcher came to attend to the patients, as he stays approximately 10 minutes from the 
BGH. In cases when the researcher could not come, the ED staff discussed with the patients 
and agreed on the need to collect data on the next day of admission by the researcher in the 
medical ward for in-hospital treatment patients. For patients who were discharged home, the 
ED staff collected all the data required for the study. Also, prior to collecting data the 
researcher had a meeting with the ED colleagues in which they agreed on a common 
understanding on the PEF procedure.2,10 By the end of data collection process ninety percent 
of data had been collected by the researcher personally and the remaining ten percent by the 
ED colleagues. 
   
 3.10. Data analysis64 
The collected data was entered on an ExcelTM spread sheet. Statistical data analysis was 
carried out using Stata version 12 software, and charts to present data were constructed in 
Excel. Descriptive statistics, such as means and standard deviations (SD), or medians and 
ranges, were used to summarize quantitative characteristics. A Pie chart was used to 
graphically display the categorical characteristics, such as proportion of patients presenting 
with acute asthma attack in ED. A frequency histogram was constructed to present the 
distribution of quantitative data, such as severity of acute asthma. Frequencies and 
percentages were used to summarize categorical characteristics such as gender, asthma 
triggers, adherence to asthma treatment, level of education, and acute respiratory infection.  
 
The Chi-square test or Fisher exact test (FET) was used to test the associations between 
different variables (age, gender, race, level of education, employment and occupation status, 
type of housing, acute respiratory infection, adherence to asthma treatment, medication-
related asthma triggers, active and passive cigarette smoking, and stress or anxiety) across 
acute asthma attack severity. FET was used when the expected numbers of subjects in the 
cells were less than five. Bivariate logistic regression was used to ascertain factors and/or 
triggers associated with acute asthma attack presentation in the ED. Odds ratios (OR) with 
95% CI and p-values were tabulated to describe the strength of these associations. P-values 
less than 0.05 were considered statistically significant.  
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3.11. Ethical considerations 
The research was approved by the Human Research Ethics Committee (HREC) of the 
University of the Witwatersrand (Protocol approval number M141115 – see Appendix E). 
The researcher also had permission from the Ekurhuleni Health District Research Committee 
(Appendix F), the Chief Executive Officer (CEO) and the head of the ED of the BGH before 
data collection started. The BGH ED doctors were informed about the study and requested to 
volunteer to participate (Appendix C). Using a subject information form, research 
participants were informed about the study and a written informed consent was obtained from 
them (Appendix D). Confidentiality was maintained by not using patient names but giving a 
unique patient identification number (PIN) to each patient, starting from 001 (Appendix G). 
The PINs were known only to the researcher and the supervisors of the study. The next 
chapter describes the results of the study. 
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CHAPTER 4  
RESULTS  
This chapter describes the findings of the study. It includes the following results: proportion 
of patients presenting with acute asthma attack at the BGH ED, severity assessment of their 
acute asthma attack, their socio-demographic characteristics, and the associations between 
variables (age, gender, race, level of education, employment and occupation status, type of 
housing, active and passive cigarette smoking, acute respiratory infection, medication-related 
asthma triggers, adherence to asthma treatment, knowledge of asthma allergens, and stress or 
anxiety) across acute asthma attack severity to ascertain significant factors and/or triggers 
associated with acute asthma attack in these patients. 
4.1. Proportion of patients presenting with acute asthma attack at the 
Bertha Gxowa Hospital Emergency Department 
 
During the study period from 01st February 2015, 00h 00, to 30th April 2015, 00h 00, a total 
of 5260 patients presented at BGH ED with various health conditions, including acute asthma 
attack. Of these 5260 patients, a total of 251 (4.77%) had asthma exacerbation and were 
enrolled in the study (Figure 4.1). From these 251 acute asthma attack patients, twelve were 
excluded from the study: four refused to participate and eight had clinical conditions which 
did not allow PEF assessment. No patient was excluded from the study because he/she did 
not understand English language. As a result, 239 asthmatic patients were analysed. 
                            
                             Figure 4.1: Proportion of acute asthma attack at the BGH ED 
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4.2. Severity assessment of acute asthma attack of patients presenting at the 
BGH ED 
Figure 4.2 displays the assessment of the severity of acute asthma attack of patients 
presenting at the BGH ED.  
             
Figure 4.2: Severity assessment of acute asthma attack of patients  
Eight out of 247 acute asthma patients (3.20%) were not able to perform a PEF assessment 
because of their clinical conditions at the presentation to the hospital ED. Therefore, they 
were excluded from the study. It is possible that some of these excluded patients had 
imminent respiratory arrest asthma exacerbation. Consequently, this category of asthma 
exacerbation was not reported in the study.  
 
4.3. Socio-demographic factors of the study participants 
4.3.1. Age  
The findings related to ages of patients are shown in Table 4.1. The median age was 31 years 
and age ranged from 18 years to 75 years. 
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Table 4.1: Percentage distribution between age group and acute asthma attack severity 
of patients  
Age group Frequency 
of age 
group 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
18-24 26.78% 34.38% 48.44% 17.19% 100.00% 
25-34 31.80% 38.16% 51.32% 10.53% 100.00% 
35-44 12.97% 19.35% 70.97% 9.68% 100.00% 
45-54 12.13% 31.03% 51.72% 17.24% 100.00% 
55-64 9.21% 31.82% 54.55% 13.64% 100.00% 
65-75 7.11% 52.94% 41.18% 5.88% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
 
The Chi-square statistic for the association between age and acute asthma attack severity of 
patients presenting at the BGH ED gave the following results: Pearson Chi2 = 9.4179, degree 
of freedom = 10 and p = 0.523. Further analysis with the bivariate logistic regression model 
gave the following results: (OR 0.99, 95% CI: 0.97 to 1.02; p = 0.592) (Table 4.17). In the 
logistic regression calculation, the outcome is categorized into severe versus mild/moderate.  
4.3.2. Gender 
The findings of the gender distribution of the patients are shown in Table 4.2.  
 
Table 4.2: Percentage distribution between gender and acute asthma attack severity of 
patients  
Gender Frequency 
of gender 
Mild 
attack  
Moderate 
attack  
 
Severe 
attack  
Total 
Male 58.18% 37.41% 51.80% 10.79% 100.00% 
Female 41.82% 30.00% 54.00% 16.00% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                                         
The Chi-square statistic for the association between gender and acute asthma attack severity 
of patients presenting at the BGH ED gave the following results: Chi2 = 2.2007, degree of 
freedom = 2 and p = 0.333. Further analysis with the bivariate logistic regression model gave 
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the following results: (OR 1.57, 95% CI: 0.74 to 3.36; p = 0.240) (Table 4.16). In the logistic 
regression calculation, the outcome is categorized into severe versus mild/moderate.  
4.3.3. Race  
The racial distribution of the patients is shown in Table 4.3.  
Table 4.3: Percentage distribution between race and acute asthma attack severity of 
patients  
Race Frequency 
of race 
Mild attack Moderate 
attack 
Severe 
attack 
Total 
White 8.37% 40.00% 55.00% 5.00% 100.00% 
Black 63.18% 35.10% 50.99% 13.91% 100.00% 
Indian 11.72% 28.57% 64.29% 7.14% 100.00% 
Coloured 16.74% 32.50% 50.00% 17.50% 100.00% 
                                            
The Chi-square statistic for the association between race and acute asthma attack severity of 
patients presenting at the BGH ED gave the following results: Chi2 = 3.8423, degrees of 
freedom = 6 and p = 0.759. Further analysis using the bivariate logistic regression model 
gave the following results, where the white race was used as the reference category: black 
(OR 3.07, 95% CI: 0.39 to 24.15; p = 0.287), Indian (OR 1.46, 95% CI: 0.12 to 17.32; p = 
0.764) and coloured (OR 4.03, 95% CI: 0.46 to 35.50; p = 0.208) (Table 4.17). In the logistic 
regression calculation, the outcome was categorized into severe versus mild/moderate. 
4.3.4. Employment status  
The results of the employment status of the patients are shown in Table 4.4.  
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Table 4.4:  Percentage distribution between employment status and acute asthma 
attack severity of patients  
Employment 
status 
Frequency 
of 
employment 
status 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
Employed 83.26% 32.16% 53.77% 14.07% 100.00% 
Not employed 16.74% 45.00% 47.50% 7.50% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                           
The Chi-square statistic for the association between employment status and acute asthma 
attack severity of patients presenting at the BGH ED gave the following results: Chi2 = 
2.9570, degree of freedom = 2 and p = 0.256. Further analysis with the bivariate logistic 
regression model gave the following results: (OR 0.5, 95% CI: 0.14 to 1.72; p = 0.268) 
(Table 4.17). In the logistic regression calculation, the outcome was categorized into severe 
versus mild/moderate. 
4.3.5. Occupation status  
The results of the occupation status of patients are shown in Table 4.5.  
Table 4.5:  Percentage distribution between occupation status and acute asthma attack 
severity of patients  
Occupation 
status 
Frequency 
of 
occupation 
status 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
No occupation 16.32% 46.15% 46.15% 7.69% 100.00% 
 Occupation 83.63% 32.00% 54.00% 14.00% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                               
The Chi-square statistic for the association between occupation status and acute asthma attack 
severity of patients presenting at the BGH ED gave the following results: Chi2 = 2.2878, 
degree of freedom = 2 and p = 0.212. Further analysis with the bivariate logistic regression 
model gave the following results: (OR 1.95, 95% CI: 0.56 to 6.78; p = 0.291) (Table 4.17). In 
the logistic regression calculation, the outcome was categorized into severe versus 
mild/moderate. 
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4.3.6. Level of education  
The level of education of the patients is shown in Table 4.6.  
Table 4.6: Percentage distribution between level of education and acute asthma attack 
severity of patients  
Level of 
education 
Frequency 
of level of 
education 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
No school 2.93% 71.43% 14.29% 14.29% 100.00% 
Secondary  77.82% 31.72% 52.15% 16.13% 100.00% 
Tertiary 19.25% 39.13% 60.87% 0.00% 100.00% 
Total 100.00% 34.30% 52.72% 12.97% 100.00% 
 
 The Chi-square statistic for the association between level of education and acute asthma 
attack severity of patients presenting at the BGH ED gave the following results: Chi2 = 
14.4447, degree of freedom = 4 and p < 0.001. Further analysis with the bivariate logistic 
regression model gave the following results: (OR 1.15, 95% CI: 0.13 to 9.93; p = 0.896) 
(Table 4.17). In the logistic regression calculation, the outcome was categorized into severe 
versus mild/moderate. Also, there were too few study participants with no schooling, and 
therefore this category could not be included in the logistic regression calculation. 
4.3.7. Type of housing  
The type of housing of the patients is shown in Table 4.7. 
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Table 4.7: Percentage distribution between housing type and acute asthma attack 
severity of patients  
Type of 
housing 
Frequency 
of type of 
housing 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
RDP 1.26% 66.67% 33.33% - - 100.00% 
IS or SC 1.26% - - 100.00% - - 100.00% 
Hostel 0.84% - - 100.00% - - 100.00% 
Flat 71.55% 33.92% 52.63% 13.45% 100.00% 
Townhouse 25.10% 36.67% 50.00% 13.33% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                                                         - - : zero percent 
The Chi-square statistic for the association between the type of housing and acute asthma 
attack severity of patients presenting at the BGH ED gave the following results: Chi2 = 
6.2282, degree of freedom = 8 and p = 0.822. Further analysis with the bivariate logistic 
regression model gave the following results: (OR 0.99, 95% CI: 0.42 to 2.35; p = 0.982) 
(Table 4.17). In the logistic regression calculation, the outcome was categorized into severe 
versus mild/moderate. 
4.3.8. Smoking status  
The current smoking status of the patients is shown in Table 4.8. 
 
Table 4.8: Percentage distribution between cigarette smoking status and acute asthma 
attack severity of patients  
Cigarette 
smoking  
Frequency 
of 
cigarette 
smoking 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
 Yes 15.06% 22.22% 30.56% 47.22% 100.00% 
 No 84.96% 36.45% 56.65% 6.90% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
 
The Chi-square statistic for the association between cigarette smoking and acute asthma 
attack severity of patients presenting at the BGH ED gave the following results: Chi2 = 
44.0897, degree of freedom = 2 and p < 0.001. Further analysis with the bivariate logistic 
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regression model gave the following results: (OR 12.08, 95% CI: 5.16 to 28.27; p < 0.001) 
(Table 4.17). In the logistic regression calculation, the outcome was categorized into severe 
versus mild/moderate. 
4.3.8.1. Number of cigarettes smoked per day  
Table 4.9 shows the results of the number of cigarettes smoked per day by the patients.  
 
Table 4.9: Percentage distribution between number of cigarettes smoked per day and 
acute asthma attack severity of patients  
Numbers of 
cigarettes 
smoked per day 
Frequency 
of 
cigarettes 
smoked per 
day 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
< 5 38.89% 42.86% 35.71% 21.43% 100.00% 
5 -10 50.00% 11.11% 33.33% 55.56% 100.00% 
> 10 11.11% -- -- 25.00% 75.00% 100.00% 
Total 100.00% 22.200% 33.33% 44.44% 100.00% 
                                                                    - -: zero percent 
The Chi-square statistic for the association between numbers of cigarettes smoked per day 
and acute asthma attack severity of patients presenting at the BGH ED gave the following 
results: Chi2 = 7.6875, degree of freedom = 2 and p = 0.114. Further analysis with the 
bivariate logistic regression model gave the following results: (OR 4.58, 95% CI: 0.94 to 
22.24; p = 0.059) (Table 4.17). In the logistic regression calculation, the outcome was 
categorized into severe versus mild/moderate. 
4.3.9. Cigarettes smoked by a household member 
Table 4.10 shows the results of passive cigarette smoking of the patients.  
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Table 4.10: Percentage distribution between cigarette smoking by a household and 
acute asthma attack severity of patients  
Cigarette 
smoking by a 
household 
Frequency 
of passive 
cigarette 
smoking 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
Yes 22.19% 28.57% 42.86% 28.57% 100.00% 
No 77.82% 35.29% 54.41% 10.29% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                                  
The Chi-square statistic for the association between cigarette smoking by a household (a form 
of passive cigarette smoking) and acute asthma attack severity of patients presenting at the 
BGH ED gave the following results: Chi2 = 8.8442, degree of freedom = 2 and p = 0.012. 
Further analysis with the bivariate logistic regression model gave the following results: (OR 
3.49, 95% CI: 1.47 to 8.25; P < 0.004) (Table 4.17). In the logistic regression calculation, the 
outcome was categorized into severe versus mild/moderate. 
4.4. Clinical factors 
4.4.1. Acute respiratory infection  
Table 4.11 shows the presence of acute respiratory tract infections among the patients.  
Table 4.11: Percentage distribution between acute respiratory infection and acute 
asthma attack severity of patients  
Acute 
infection 
Frequency 
of acute 
infection 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
None 89.12% 33.33% 53.52% 13.15% 100.00 
URTI 10.05% 41.67% 45.83% 12.50% 100.00 
LRTI 0.84% 50.00% 50.00% - - 100.00 
Total 100.00% 34.31% 52.72% 12.97% 100.00 
                                                                            - -: zero percent 
The Chi-square statistic for the association between acute respiratory tract infection and acute 
asthma attack severity of patients presenting at the BGH ED gave the following results: Chi2 
= 1.0945, degree of freedom = 4 and p = 0.873. Further analysis with the bivariate logistic 
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regression model gave the following results: (OR 0.86, 95% CI: 0.24 to 3.06; p = 0.818) 
(Table 4.17). In the logistic regression calculation, the outcome was categorized into severe 
versus mild/moderate. 
4.4.2. Use of medication-related asthma triggers  
Table 4.12 shows the use of medication-related asthma triggers by the patients 
 
Table 4.12: Percentage distribution between medication-related asthma triggers and 
acute asthma attack severity of patients  
Medication 
used 
Frequency 
of 
medication 
used 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
None 97.91% 33.76% 52.99% 13.25% 100.00 
NSAIDs 2.09% 60.00% 40.00% - - 100.00 
Total 100.00% 34.31% 52.72% 12.97% 100.00 
                                                                      - -: zero percent 
The Chi-square statistic for the association between use of medications known to trigger 
asthma exacerbation and acute asthma attack severity of patients presenting at the BGH ED 
gave the following results: Chi2 = 1.8015, degree of freedom = 2 and p = 0.432. Further 
analysis with the bivariate logistic regression model gave the following results: (OR 0.95, 
95% CI: 0.27 to 3.41; p = 0.942) (Table 4.17). In the logistic regression calculation, the 
outcome was categorized into severe versus mild/moderate. 
4.4.3. Adherence to asthma treatment 
Table 4.13 shows adherence status to asthma treatment of the patients  
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Table 4.13: Percentage distribution between adherence to asthma treatment and acute 
asthma attack severity of patients  
Adherence Frequency 
of 
adherence 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
Yes 58.00% 32.57% 54.59% 12.84% 100.00% 
No 40.00% 64.29% 28.57% 7.14% 100.00% 
Not sure 2.00% 28.57% 42.86% 28.57% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                        
The Chi-square statistic for the association between adherence to asthma treatment and acute 
asthma attack severity of patients presenting at the BGH ED gave the following results: (Chi2 
= 24.5349, degree of freedom = 4 and p < 0.001). Further analysis with the bivariate logistic 
regression model gave the following results: (OR 11.09, 95% CI: 4.31 to 27.09; p < 0.001) 
(Table 4.17). In the logistic regression calculation, the outcome was categorized into severe 
versus mild/moderate. 
4.4.4. Asthma allergens and its knowledge score  
4.4.4.1. Knowledge of asthma allergens  
Table 4.14 shows knowledge of asthma allergens distribution of the patients.  
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Table 4.14: Percentage distribution of knowledge of asthma allergens of patients  
Allergen type 
Frequency 
of correct 
answers  
Cigarette smoke 100.00% 
Cold weather 96.65% 
Feathers 95.82% 
Dust at home or street 94.77% 
Chemicals like paint, detergents, soap 93.10% 
Spray from deodorant, perfume and air 
fresher 
92.68% 
Seeds from weed or grass 91.25% 
Pollen 89.96% 
Cockroaches 83.20% 
Fruits like peanut and mango 81.59% 
Smoke from coal, fire, wood and 
paraffin stoves 
79.55% 
Red wine 74.48% 
Cat 66.53% 
Yellow/orange flavoured/coloured food 59.00% 
 
4.4.4.2. Asthma allergens knowledge score  
Each of the patients was given a score on knowledge regarding asthma allergens. Each 
correct answer was given a score of ‘1’ and each wrong answer was given a score of ‘0’. A 
total score of 27 means that the participant knows all the 27 asthma allergens asked in the 
study questionnaire (Appendix B); higher scores close to 27 imply higher knowledge on 
asthma allergens. The mean (SD) of the score was 24.3 (1.3), indicating a very high 
knowledge of asthma allergens among the patients. Their scores ranged from 20 to 26 as 
shown in Table 4.15. 
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Table 4.15: Percentage distribution between knowledge of asthma allergens and acute 
asthma attack severity of patients  
Asthma 
knowledge score 
Frequency 
of 
knowledge 
score 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
Total 
20 2.09% - - 60.00% 40.00% 100.00% 
21 2.51% 33.33% 33.33% 33.33% 100.00% 
22 2.51% 16.67% 83.33% - - 100.00% 
23 6.70% 37.50% 43.75% 18.75% 100.00% 
24 43.09% 33.98% 53.40% 12.62% 100.00% 
25 25.10% 41.67% 48.33% 10.00% 100.00% 
26 17.99% 30.23% 58.14% 11.63% 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
                                                              --: zero percent 
The Chi-square statistic for the association between asthma knowledge score of asthma 
allergens and acute asthma severity of patients presenting at the BGH ED gave the following 
results: Pearson Chi2 = 12.1257, degree of freedom = 12 and p = 0.462. Further analysis with 
the bivariate logistic regression model gave the following results: (OR 0.79, 95% CI: 0.60 to 
1.03; p = 0.086) (Table 4.17). In the logistic regression calculation, the outcome was 
categorized into severe versus mild/moderate. 
4.5. Psychological factor  
4.5.1. Stress or anxiety  
Table 4.16 shows the distribution of stress or anxiety of the patients.    
 
Table 4.16: Percentage distribution of stress or anxiety of and acute asthma attack 
severity of patients  
Condition 
reported 
Frequency 
of 
conditions 
Mild 
attack 
Moderate 
attack 
Severe 
attack 
    Total  
None  84.94% 35.96% 51.72% 12.32% 100.00% 
Stress 14.64% 25.71% 57.14% 17.14% 100.00% 
Anxiety 0.42% - - 100.00% - - 100.00% 
Total 100.00% 34.31% 52.72% 12.97% 100.00% 
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The Chi-square statistic between suffering from stress or anxiety and acute asthma attack 
severity of patients presenting at the BGH ED gave the following results: Chi2 = 2.5167, 
degree of freedom = 4, p = 0.590. Further analysis with the bivariate logistic regression 
model gave the following results: (OR 1.42, 95% CI: 0.54 to 3.76; p = 0.476) (Table 4.16). In 
the logistic regression calculation, the outcome was categorized into severe versus 
mild/moderate. 
4.6. Logistic regression results 
Table 4.17 shows the results of bivariate logistic regression between different variables (age, 
gender, race, level of education, employment and occupation status, type of housing, active 
and passive cigarette smoking, acute respiratory tract infection, medication-related asthma 
triggers, adherence to asthma treatment, knowledge of asthma allergens, and stress or 
anxiety) and acute asthma severity of patients presenting at the BGH ED. 
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Table 4.17: Bivariate logistic regression results between variables and acute asthma 
attack severity of patients  
    Variables OR 95%CI p-value 
Age (years) 0.99 0.97 to 1.02 0.592 
Female gender 1.57 0.74 to 3.36 0.24 
Race 
   White Reference 
  Black 3.07 0.39 to 24.15 0.287 
Indian 1.46 0.12 to 17.32 0.764 
Other 4.03 0.46 to 35.30 0.208 
Employment 0.5 0.14 to 1.72 0.268 
Occupation 1.95 0.56 to 6.78 0.291 
Education  
   Secondary Reference 
  Tertiary 1.15 0.13 to 9.93 0.896 
Housing 
   Flat Reference 
  Townhouse 0.99 0.42 to 2.35 0.982 
Acute respiratory 
infection 
   None Reference 
  
             URTI 
 
0.86 
 
0.24 to 3.06 0.818 
Not adherent 11.09 4.31 to 27.09 <0.001 
Medication-related 
asthma triggers 0.95 0.27 to 3.41 0.942 
Asthma allergens 
knowledge score 0.79 0.60 to 1.03 0.086 
Smoking 12.08 5.16 to 28.27 <0.001 
Number of cigarettes 
smoked per day 
<5 
5-10 
>11 
Reference 
4.58 
11.00 
0.94 to 22.24 
0.82 to 147.87 
0.059 
0.070 
 
Someone smoking at 
home 3.49 1.47 to 8.25 0.476 
Stress or anxiety 1.42 0.54 to 3.76 0.476 
                                                             
The results of the bivariate logistic regression show that adhering to asthma treatment (OR 
11.09, 95% CI: 4.31 to 27.09; p < 0.001), active cigarette smoking (OR 12.08, 95% CI: 5.16 
to 28.27; p < 0.001) and passive cigarette smoking (OR 3.49, 95% CI: 1.47 to 8.25; p = 
0.004) were the only statistically significant factors. For the calculation of the bivariate 
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logistic regression, acute asthma severity was tabulated in two groups, namely mild/moderate 
and severe acute asthma attack. 
The bivariate logistic regression results show no significant association between level of 
education and acute asthma attack severity. However, the results of FET described above 
(Table 4.6) are not in line with this conclusion (p < 0.001). This difference in results is 
explained by the fact that there were too few patients with no schooling, and therefore it was 
not possible to include this category in the logistic regression calculation.  
4.7. Summary of main study findings 
The key findings from the study are as follows: the proportion of patients presenting with 
acute asthma attack at the BGH ED was 4.77%. The majority of them had moderate acute 
asthma attack (52.72%), were black (63.18%), young adults (83.68%), males (58.18%), 
completed secondary school (77.82%), employed (83.26%), had an occupation (83.63%), live 
in modern or urban type of house (96.65%), and were adherent to their asthma treatment 
(58.00%).  
Low level of education (p < 0.001) was a significant factor associated with acute asthma 
attack presentation. Active cigarette smoking (p < 0.001) and/or passive cigarette smoking (p 
= 0.004) were identified to be potential triggers associated with acute asthma attack. There 
were no significant associations between acute asthma attack severity and age (p = 0.592), 
gender (p = 0.240), race (p = 0.759), occupation status (p = 0.291), employment status (p = 
0.268), number of cigarettes smoked per day (p = 0.059), type of housing (p = 0,982), acute 
respiratory tract infection (p = 0.818), use of medication-related asthma triggers (p = 0.942), 
knowledge of asthma allergens (p = 0.086), and stress or anxiety (p = 0.475). The next 
chapter will discuss the findings of the study. 
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CHAPTER 5 
DISCUSSION 
This chapter contains a discussion of key findings of the results presented in the preceding 
chapter in light of the literature review. It includes the following discussion: the proportion of 
patients presenting with acute asthma attack at the BGH ED, their acute asthma severity 
assessment and socio-demographic characteristics, and the results of associations between 
different variables and acute asthma attack severity of these patients. 
5.1. Proportion of patients presenting with acute asthma attack at the 
Bertha Gxowa Hospital Emergency Department 
The results have shown that the proportion of patients presenting with acute asthma attack at 
the BGH ED is about 4.77%. This relatively low proportion was not surprising and is 
consistent with other studies.18 A proportion as low as 2.50% was reported by Kirenga et al. 
in their study in Uganda.18 Other studies have reported contradictory results that indicated 
higher proportions of acute asthma attack in an ED.14,19 South African study by Westerman et 
al. described above, on the magnitude of the asthma problem at Groote Schuur Hospital, in 
Cape Town, reported a proportion of 10.0%.14 In their study of multicentre observational 
analysis of adults with asthma exacerbation in ED, Watase et al. in Japan reported a 
proportion as high as 47%.19  
The difference in proportions is explained by the socio-cultural habits of the population 
studied and the organization of healthcare system of country where the study is undertaken, 
including study site and level of care.10,18 In the study by Kirenga et al. described above, 
patients with asthma exacerbation were managed in both the ED and respiratory clinic in the 
hospital where the study was conducted.18 Importantly, both proportions (2.5% and 16.9% in 
the ED and respiratory clinic, respectively) were reported by the authors.18 In the RSA, 
patients with acute asthma attack are mainly managed in ED, and a respiratory clinic is 
reserved more for patients in need of a pulmonology consultation.15 Thus, if this practice was 
followed in Uganda there could be the possibility of Sanya et al. reporting a higher proportion 
of asthma exacerbation in ED. 
38  
 
A study conducted in a tertiary hospital is expected to report lower proportions of many 
health conditions, including acute asthma attack compared with the one conducted in a 
district hospital, which is the first point-of-care of most patients.59 However, this was not the 
case with the Cape Town study conducted in a tertiary health facility by Westerman et al., 
which reported a significant proportion (10%) of acute asthma attack in ED,14 whereas our 
study was conducted in a district hospital but found a lower proportion of asthma 
exacerbation in ED (4.77%). In addition, our study was conducted at one site, in one area of 
the country and in a public hospital setting only. This suggests that the relatively low 
proportion of acute asthma attack reported in our study has to be taken with caution. There is 
the possibility of higher proportions of acute asthma attack being reported in South African 
hospital EDs. 
Higher proportions of acute asthma attack in EDs is of concern, as this can be regarded as 
treatment failure and deemed to be preventable through an optimal asthma management by 
both HCPs and patients.57 Furthermore, ED visits imply a significant economic burden on 
healthcare spending – as much as five times more per visit than a typical outpatient visit for 
asthma.57 This had recently indicated the importance of determining the reasons for ED visits 
for acute asthma attack. Hasegawa et al. concluded from both their bivariate and multivariate 
models that the use of EDs as the preferred source of asthma prescription was one of the 
significant reasons for ED visits by asthmatic patients (all p < 0.005).57 This was an 
interesting study which included 64 USA EDs, a large sample size (1095), a design (cohort) 
of good evidence level and a study population comprising a diverse spectrum of ethnic 
groups of adult patients.57,64 This indicates that asthmatic patients have possibly other reasons 
than seeking treatment for asthma exacerbation in ED, and addressing them may potentially 
reduce the higher rates of asthma exacerbation in EDs documented worldwide, including in 
South Africa.2,9,10,49,57-59 
5.2. Acute asthma severity assessment of patients presenting at the BGH 
ED 
The results have shown that patients presented with mild, moderate and severe acute asthma 
exacerbations at the BGH ED. In the study the majority of patients (52.72%) had moderate 
acute asthma attack. This is in line with the studies described above, by Dankner et al. in 
Israel and by Westerman et al. in Cape Town al.14,21 This is in contrast with the study by 
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Refaat et al. in Egypt in which they found a large proportion (52.6%) of patients had severe 
acute asthma attack.22  
The difference in proportions of moderate and severe acute asthma attack between studies is 
explained by many factors, including the guidelines used to classify asthmatic patients in ED, 
the social habits (i.e. cigarette smoking) of the study participants, and adherence to asthma 
treatment, occupation status, help-seeking behaviour and other factors like the presence of 
acute viral respiratory infection and asthma allergens.10,22 For example, in their study Refaat 
et al. assessed acute asthma attack severity based on the Expert Panel Report-3 (EPR-3) of 
2007, which categorized the attack based on PEF, above 70% as mild, between 69% to 40% 
as moderate, and below 40% as severe,22 whereas the WGSATS guideline defines acute 
asthma attack as mild if PEF is above 80%, moderate between 80% and 60%, and severe if 
PEF is below 60%.9 Refaat et al. could thus have reported an even higher proportion of 
severe asthma exacerbation than the actual proportion documented in their study (52.6%) if 
they had used the WGSATS guideline, as there are significant differences in PEF values 
between the two guidelines.9,22  
Cigarette smoking is one of the main factors associated with severe acute asthma attack 
presentation.10 The studies by Hasegawa et al. in USA and the study by Watase et al. in Japon 
found that cigarette smoking was a significant factor associated with severe asthma 
exacerbation in ED.19,57 In addition to this, the authors of these studies demonstrated that 
current cigarette smoking was significantly associated with frequent ED visits (all p < 
0.05).19,61 The study by Hasegawa et al. is described above.57 The study by Watase et al. 
included 23 EDs across Japan and was conducted over a two-year period. It had a large 
sample size (1002), a mixture of ethnic groups of adult patients, and a design (multicentre 
chart review) of good evidence level.19,64 The findings of these two studies can be 
generalized, as their large sample sizes gave them enough statistical powers, in addition to 
their good study designs and the ethnic composition of the participants.64  
Furthermore, in the study by Refaat et al. described above, 25.40% of patients were currently 
smokers,22 whereas there were only 15.06% in our study. Thus, it is possible that the higher 
rate of severe asthma exacerbation documented by Refaat et al. compared to that from our 
study could be due to the significant number of current cigarette smokers in their study.22 
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5.3. Socio-demographic characteristics of the patients 
5.3.1. Demographic characteristics 
The results have shown that patients were mostly adults (18 years to 54 years: 84.00%) with a 
predominance of male gender (58.00%). This was similar to the findings of many European 
studies.3,5 This was in contrast with the study by Westerman et al. in Cape Town.14 Other 
studies have documented a predominance of female gender.22,57 Examples include the study 
by Scharts et al. in the USA and the study by Refaat et al. in Egypt.22,58 
The overall median age was 31 years, which was similar to the median age 33 years reported 
by Sanya et al. in Uganda23 and 35 years reported by Refaat et al. in Egypt,22 but lower than 
the median age of 41 years reported by Pearson et al. in the United Kingdom (UK).59 The 
difference in the age range could be explained by the longer life expectancy of the population 
of developed countries compared to that of the African population.60 The UK is a developed 
country where the life expectancy of the population is estimated to be longer (81 years) than 
that of Egypt (71 years), South Africa (60 years), and Uganda (59 years) population.60 The 
youngest patient was 18 years old and the oldest patient was 78 years old. This was similar to 
the adult age range (18 years to 73 years) reported by Bellamy et al.,61 but was in contrast 
with the age range (16 to 94 years) reported by Pearson et al.59 
The results have shown that the majority of the patients (63.00%) were black (Table 4.3). 
This was similar to the findings of an American study of the impact on race on the severity of 
acute episode of asthma by El-Ekiaby et al.62 This was in contrast with the study by 
Westerman et al. in Cape Town, which found that the majority of patients were white, 
followed by blacks.14 The difference in findings can be explained by country, country politics 
and study site, including urban and rural areas. A study conducted in a predominantly black 
African country is expected to report a majority of blacks. The South African study by 
Westerman described above was conducted during the apartheid period, when the black 
population had difficulty in accessing medical care in South Africa. Consequently, the 
authors reported a majority of whites in their study population.14  
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5.3.2. Social characteristics  
The results show that the majority of the patients were employed (83.00%) or had an 
occupation (84.00%). This was similar to the conclusion of the study by Sanya et al. in 
Uganda.23 This was not in line with the study by Fernandes et al. in Brazil.27 This was also 
not in line with the findings reported by Schwenkglenks et al. in Swaziland.32 In terms of 
level of education, the majority of the patients (88.00%) completed secondary school, 
followed by tertiary school. This was similar to the findings of the study described above by 
Fernandes et al. in Brazil.27 This was in contrast with the study by Geyser et al. at Kalafong 
Hospital in Pretoria.49 The majority of patients (97.00%) in the study live in modern or urban 
type of housing. The study by Van der Merwe in Cape Town described above reported the 
same conclusion.15 This was also similar to the study by Eisner et al. in California.25  
5.4. Factors and/or triggers associated with acute asthma attack in patients 
presenting at the BGH ED 
5.4.1. Age  
The Chi-square statistic revealed no significant association between age and acute asthma 
attack (p = 0.523). This is in line with the results of the logistic regression (OR 0.99, 95% CI: 
0.97 to 1.02; p = 0.592). Thus, age was not a significant factor associated with acute asthma 
attack in these patients. This conclusion has been found in many other studies.23,27,49,63 In 
their study Sanya et al. found that age was not a significant factor associated with asthma 
exacerbation (OR 0.75, 95% CI: 0.523 to 1.090; p = 0.710).23 This was also similar to the 
findings by Fernandes et al. in Brazil (OR 1.001, 95% CI: 0.994 to 1.009; p = 0.781).27 Other 
studies have reported contradictory results, in the sense that belonging to a certain age group 
is a significant factor associated with asthma exacerbation and/or hospitalization.63 The study 
by Bavbek et al. on the risk factors associated with hospitalizations for asthma attacks in 
Turkey found that advanced age was a significant factor associated with acute asthma attack 
and/or hospitalization (p < 0.001).26 The study by Brandao et al. in Brazil and the study by 
Omachi et al. in USA have also arrived at the same conclusion that advanced age was a 
potential factor associated with asthma exacerbation.33,63  
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5.4.2. Gender  
The Chi-square statistic revealed no significant association between gender and acute asthma 
attack (p = 0.333). This is in line with the results of the logistic regression (OR 1.57, 95% CI: 
0.74 to 3.36; p = 0.24). Thus, gender was not a significant factor associated with acute asthma 
attack in these patients. This was similar to the study described above by Omachi et al. in 
USA.63 This was in contrast with the case-control study by Van der Merwe et al. in Cape 
Town, which found that female gender was a significant factor associated with severe life-
threatening asthma (OR 3.3, 95% CI: 1.2 to 9.6; p = 0.02).15 This conclusion was in contrast 
with the findings by Fernandes et al. that male gender was significantly and independently 
associated with severe asthma exacerbation and/or death (OR 5.392, 95% CI: 2.373 to 
12.254; p < 0.001).27 This was attributed to non-adherence to asthma treatment and the failure 
to achieve good chronic asthma control in male asthmatic patients.27   
 
In this study, the researcher did not investigate the gender distribution across adherence to 
asthma treatment. However, studies have documented conflicting reports with regard to 
gender distribution across adherence to the recommended treatment regimen.51,51 Recently, 
Manteuffel et al. in the USA evaluated the differences between women and men in 
medication use, medication adherence, and prescribing alignment with clinical guidelines.52 
They included 29.5 million adults aged 18 and older, with a variety of acute and chronic 
health conditions.52 They found that women were significantly more likely than men to use ≥ 
1 acute medications (68% vs. 59%, respectively, p < 0.001), whereas they were less likely 
than men to be adherent in their use of chronic medications (p < 0.0001).52 In their study of 
asthma in men and women, treatment adherence, anxiety, and quality of sleep, Sandberg et al. 
in Sweden found that women had a significantly reduced risk of non-adherence to their use of 
chronic asthma medication (OR 0.64, p = 0.02).51 In addition to this, the authors of this study 
demonstrated that at exacerbation in asthma, women had a significantly greater risk of 
adherence to their asthma medication (OR 0.46, p < 0.0001).51   
 
5.4.3. Race  
The Chi-square statistic revealed no significant association between race and acute asthma 
attack (p = 0.759). This is in line with the results of the logistic regression (black: OR 3.07, 
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95% CI: 0.39 to 24.15; p = 0.287, Indian: OR 1.46, 95% CI: 0.12 to 17.32; p = 0.764, and 
coloured: OR 4.03, 95% CI: 0.46 to 35.50; p = 0.208). Thus, race was not a significant factor 
associated with acute asthma attack in these patients. This observation is striking in this 
context, given that multiple prior studies have demonstrated a markedly greater association 
between race and asthma exacerbation.25,30,63 The study by Omachi et al. found that African-
American race was significantly associated with lower risk of severe asthma exacerbation and 
death (p = 0.04) compared to whites.63 The study by Boudreaux et al. found that more black 
than white people had severe acute asthma (p < 0.001).30 The study by Eisner et al. also 
found a significant association between non-white (non-Hispanic) race/ethnicity and risk of 
hospitalization in asthmatic patients (OR 3.1, 95% CI: 1.10 to 8.80).25 In addition to this, the 
authors of this study found that African-American race was associated with increased risk of 
hospitalization, compared with whites, non-Hispanic persons (OR 10.2, 95% CI: 1.80 to 
58.4); and Hispanic race/ethnicity also appeared to be related to hospitalization (OR 4.09, 
95% CI: 0.9 to 18.0).25  In our study, white people constituted a small proportion (8.37%) 
compared to that in all studies described above.25,30,63 It is possible that this could result in 
low statistical power to detect the significant association between the overall race distribution 
and asthma exacerbation.1,63 Therefore, our conclusion has to be taken with caution. 
 
5.4.4. Occupation and employment status  
The Chi-square statistic revealed no significant association between occupation status (p = 
0.287) or employment status (p = 0.258) and acute asthma attack. This is in line with the 
results of the logistic regression (occupation status: OR 1.95, 95% CI: 0.56 to 6.78; p = 
0.291, and employment status: OR 0.5, 95% CI: 0.14 to 1.72; p = 0.268). Thus, occupation or 
employment status was not a significant factor associated with acute asthma attack in these 
patients. This conclusion has been reported by many other studies.15,17,25 However, the study 
by Fernandes et al. described above pointed in a different direction in the sense that 
unemployment was significantly associated with severe acute asthma attack (p < 0.05).27 This 
can be explained by the poor quality of life these patients experience, as demonstrated 
previously by Nogueira et al.65 Another explanation is that individuals being unemployed or 
not having an occupation are potentially at risk of having low income, which is one of the 
significant factors associated with severe asthma exacerbation as demonstrated by Eisner et 
al. (OR 1.2, 95%CI: 0.9 to 1.3).25 Importantly, there was a low proportion of no-occupation 
status (16.32%) or no-employment status (16.74%) among the patients in the study.  
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5.4.5. Level of education  
The Chi-square statistic revealed a significant association between level of education and 
acute asthma attack (p < 0.001). Patients with a lower level of education experienced severe 
asthma attack compared to patients with a higher level of education. This was not in line with 
the results of the logistic regression (OR 0.15, 95% CI: 0.13 to 9.95; p = 0.896). The 
difference in results is explained by the fact that there were too few patients with no 
schooling, and therefore it was not possible for this category to be included in the logistic 
regression calculation. Thus, this study shows that lower level of education is a significant 
factor associated with acute asthma attack. The three studies described above, namely by 
Eisner et al. in USA, Bavbek et al. in Turkey, and brandoa et al. in Brazil, came to the same 
conclusion.26,33 However, this conclusion was not in line with many other studies, namely by 
Sanya et al. in Uganda,23 by Fernandez et al. in Brazil,27 and by Omachi et al. in the USA.63 
The authors of these studies did not give the reasons of their findings. However, several 
possible explanations of the difference in findings may be given. Firstly, in the prospective 
cohort study by Brandao et al., children and adults were all included in the study (sample size 
253); and there were 43.00% of adults, very few of whom had completed tertiary education.33 
In this study, care-givers were playing a crucial role for many paediatric patients with regard 
to adherence to their asthma treatment.33 And this study was conducted in a regional 
hospital.33 Secondly, in the study by Omachi et al., the sample size was significant (865), 
comprising exclusively adult patients of a large racially diverse cohort, and including only the 
severe category of asthma exacerbation.63 These had the effect of increasing the statistical 
power to detect risk factors for severity of asthma exacerbation, making the results more 
reliable and generalizable.63,64 And the study was conducted in a regional hospital as well.63 
Lastly, our study was a cross-sectional one; conducted in a district hospital setting; focused 
exclusively on adult patients (sample size 239); and did not include imminent respiratory 
arrest asthma exacerbation category.  
Therefore, these observations show that the differences in findings between studies may be 
explained by the study’s methods, including the level of care where the study is conducted, 
the study sample size, the study inclusion and exclusion criteria, and the population studied, 
including their ages, asthma severity, and levels of schooling.  
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5.4.6 Type of housing  
The Chi-square statistic revealed no significant association between type of housing and 
acute asthma attack (p = 0.822). This is in line with the results of the logistic regression (OR 
0.99, 95% CI: 0.42 to 2.35; p = 0.982). Thus, type of housing was not a significant factor 
associated with acute asthma attack in these patients. This was not in line with the findings of 
other studies.15,25 The study by Van der Merwe et al. in Cape Town found that rural residence 
(OR 8.1, 95% CI: 2.6 to 25.3; p = 0.0005) was a significant factor associated with severe life-
threatening asthma exacerbation.15 Surprisingly, international studies had also previously 
arrived at this conclusion.34,35 Examples include the study by Tang et al. in Australia and the 
study by Higgins et al. in UK.34,35 Rural type of housing may be a marker for other asthma 
triggers, such as cockroach antigen exposure, dust, and secondhand smoke exposure.25 
Importantly, there was a very low proportion (3.00%) of patients living in a rural type of 
housing (IS, RDP and SC) in the study. However, it is possible that the small proportion of 
patients living in rural types of housing in the study means that there is not sufficient 
statistical power to detect a significant association between type of housing and asthma 
exacerbation.64 Therefore, our conclusion needs to be taken with caution. 
5.4.7 Active cigarette smoking  
The Chi-square statistic revealed a significant association between cigarette smoking and 
acute asthma attack (p < 0.001). For example, patients who smoked cigarettes were more 
likely to suffer severe acute asthma attack compared to patients who did not smoke cigarettes. 
This is in line with the results of the logistic regression (OR 12.08, 95% CI: 5.16 to 28.27; p 
< 0.001). Thus, this study demonstrates that cigarette smoking is a potential trigger associated 
with acute asthma attack. The study by Eisner et al. described above came to the same 
conclusion.25 In addition, the authors of that study demonstrated that past cigarette smoking 
was a significant associated trigger for severe acute asthma attack and/or hospitalization (OR 
1.3, 95% CI: 1.6 to 2.6).25 The study by Lkeue et al. also arrived at the same conclusion.29 
However, other studies found no statistically significant differences between smokers and 
non-smokers in relation to asthma exacerbation.23,38 Examples include the study by Sanya et 
al. in Uganda (OR 0.476, 95% CI: 0.082 to 2.745, p = 0.406) and the study by Patel et al. in 
USA (p > 0.05).18,32    
In both studies described above, namely by Eisner et al. and by Lkeue et al., there were 
significant rates of current cigarette smokers.25,29 For example, Sanya et al. reported a rate of 
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9.3%, whereas Lkeue et al. documented a rate of 35%. A large rate is representative of a true 
population studied and therefore makes the results more reliable compared to a small rate.64 
Thus, the non-significant association between current cigarette smoking and asthma 
exacerbation documented by Sanya et al. could be due to the small number of current 
cigarette smokers among their study participants.18 This could result in low statistical power 
in detecting a significant association between variables measured.64 Asthmatic patients who 
smoke cigarettes are more likely to have uncontrolled asthma than asthmatic non-smokers,36 
and this leads ultimately to an increase in the number of asthma exacerbations with 
subsequent ED visits.5,10,36 These observations sustain the association between current 
cigarette smoking and acute asthma attack documented in many studies, including ours.25,29 
5.4.7.1. Number of cigarettes smoked per day  
The Chi-square statistic revealed no significant association between number of cigarettes 
smoked per day and acute asthma attack (p = 0.114). This is in line with the results of the 
logistic regression (OR 4.58, 95% CI: 0.94 to 22.24; p = 0.059). Thus, the numbers of 
cigarettes smoked per day did not have a significant effect on asthma exacerbation in these 
patients. This conclusion was not in line with the findings documented by many studies, 
namely by Morkjaroenpong et al. in the USA, Thomson et al. in the UK, and Jindal et al. in 
India.39-41 Morkjaroenpong et al. demonstrated the strong association between numbers of 
cigarettes smoked per day and asthma exacerbations in the sense that asthmatic individuals 
who smoked greater numbers of cigarette per day (≥ 10/day) were at greater risk of 
developing severe acute asthma attack (OR 2.83, 95%CI: 1.22 to 6.55) compared to those 
who smoked less than 10 cigarettes per day.39  
Although in our study there was no significant association between numbers of cigarettes 
smoked per day and asthma exacerbation, there was a tendency towards significance, since 
the p-value is equal to 0.059. In reality, there is evidence of a difference or an impact in 
number of cigarettes smoked per day in the severity of asthma exacerbation in these patients, 
since the p-value is between 0.05 and 0.10.64 It is possible that the proportion of smokers 
(15.06%) in the study was too small to allow enough statistical power in detecting a 
significant association between numbers of cigarette smoked per day and asthma 
exacerbation in these patients.64 Another reason for the non-significance could be that the 
study did not record the actual numbers of cigarettes smoked per day; instead the researcher 
recorded only the intervals (< 5, 5 to 10, and > 10). This could also have resulted in low 
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statistical power to detect the association between numbers of cigarettes smoked per day and 
asthma exacerbation.64 
 
5.4.8. Passive cigarette smoking 
The Chi-square statistic revealed a significant association between cigarette smoking by a 
household (a form of passive cigarette smoking) and acute asthma attack (p = 0.012). Patients 
who have a household in which cigarettes are smoked were more likely to suffer severe acute 
asthma compared to patients who do not have such a household. This is in line with the 
results of the logistic regression (OR 3.49, 95% CI: 1.47 to 8.25; p = 0.004). Thus, this study 
shows that passive cigarette smoking is a potential associated trigger for acute asthma attack. 
In their cross-sectional study of passive smoking exposure, Radon et al. found that passive 
cigarette smoking was a significant associated trigger for acute asthma attack (OR 42.06, 
95% CI: 1.07 to 3.97).66 However, this was not in line with the study by Sanya et al. in 
Uganda (OR 0.405, 95% CI: 0.156 to 1.053, p = 0.064).23  
In comparing the two studies above, namely by Radon et al. and by Sanya et al., there were 
significant differences in proportions of passive cigarette smokers (62.90% vs. 39.50%, 
respectively) and in sample sizes (1890 vs. 86).23,66 The study by Sanya et al. was conducted 
at one site only, and in one country (Uganda), whereas Radon et al. included 55 sites in 23 
European countries in their study.23,66 Therefore, its large proportion of passive cigarette 
smokers, sample size, and multiple study sites make Radon et al.’s study results more reliable 
and generalizable than that of Sanya et al.64 Our findings point in the same direction as the 
study by Radon et al.: both studies highlight the exacerbating effects of passive cigarette 
smoking in asthmatic individuals as demonstrated previously.10,49 
5.4.9. Acute respiratory infection 
The Chi-square statistic revealed no significant association between acute respiratory 
infection and acute asthma attack (p = 0.873). This is in line with the results of the logistic 
regression (OR 0.86, 95% CI: 0.24 to 3.06; p = 0.818). Thus, acute respiratory infection was 
not an associated trigger for acute asthma attack in these patients. A similar conclusion was 
reported by Geyser et al. at Kalafong Hospital in Pretoria.49 This was not consistent with the 
findings by Sanya et al. in Uganda, which found that acute respiratory infection was 
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significantly associated with severe acute asthma attack (OR 4.51, 95% CI: 1.25 to 16.21; p = 
0.018).23 The literature reports that acute respiratory infection is a potential trigger associated 
with asthma exacerbation.10,23,42-44 However, our findings point in a different direction. A 
possible explanation could be that these respiratory infections were not objectively assessed 
in the study, and reliance was instead placed on patients’ self-report assessments. Also, there 
were few patients in the study with respiratory tract infections, and it is possible that this 
small proportion meant that there was insufficient statistical power to detect the significant 
association between acute respiratory infection and asthma exacerbation.64 Thus, our 
conclusion needs to be taken with caution. 
5.4.10. Medication-related asthma trigger 
The Chi-square statistic revealed no significant association between medication-related 
asthma triggers (NSAIDs) and acute asthma attack (p = 0.432). This is in line with the results 
of the logistic regression (OR 0.95, 95% CI: 0.27 to 3.41; p = 0.942). Thus, medication-
related asthma triggers were not associated triggers for acute asthma attack in these patients. 
This was similar to the conclusion reported by Geyser et al. in Pretoria (OR 1.2, 95% CI: 0.64 
to 2.76; p = 0.45).49 Sanya et al. in Uganda also came to the same conclusion.23 These 
findings were not consistent with other studies.5,10,67,69 One example is the study by Steppuhn 
et al. in Germany.69 This was an interesting study which evaluated the effects of 
Acetylsalicylic acid on asthma-related ED admissions and hospitalization.69 It included a total 
of 1136 adults from a large mixture of ethnic groups of adult patients over a one-year period. 
Steppuhn et al. found a strong association between Acetylsalicylic acid and asthma 
exacerbation (OR 45, 95%CI: 2.50 to 8.20), which persisted in the multivariate logistic model 
adjusting for gender, age group, level of body mass index, smoking status, education 
attainment, and duration of asthma.69    
Though the overall difference between medication-related asthma trigger and asthma 
exacerbation was not statistically significant in our study, a possible explanation could be the 
small proportion of medication-related asthma triggers (2.09%) in our study. It is possible 
that this proportion not being representative impacted on the outcome measured by not 
allowing sufficient statistical power to detect the difference between variables measured.1,64 
Thus, these observations indicate that our conclusion needs to be taken with caution. 
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5.4.11. Adherence to asthma treatment 
The Chi-square statistic revealed significant association between adherence to asthma 
treatment and acute asthma attack (p < 0.001). This is in line with the results of the logistic 
regression (OR 11.09, 95% CI: 4.31 to 27.09; p < 0.001). The results imply that adhering to 
asthma treatment was a significant factor associated with asthma exacerbation in these 
patients (Table 4.13). These unexpected results could be due to the fact that probably most 
patients were unwilling to admit that they were not taking their medications correctly as 
prescribed. In addition, these results could have been biased by self-reporting of adherence 
and it is possible that the results could have been different if a more objective technique of 
determining adherence to treatment was used.64 The study by Sanya et al. found a non-
significant association between non-adherence to asthma treatment and asthma exacerbation 
(OR 0.82, 95% CI: 0.35 to 19.4; p = 0.662).23  
However, this was in contrast with the study by Engelkes et al., which found that good 
adherence to treatment tends to be associated with a lower risk of severe asthma 
exacerbations.50 The study by Sanya et al. had a small sample size (86) and an unmatched 
case control design, and was conducted in one site only, between November 2011 and 
February 2012. The study by Engelkes et al. is a recent study (2015), its design (systematic 
review) is of higher level of evidence,64 and it has a large sample size from 23 publications of 
high levels of heterogeneity with regard to adherence to treatment, acute asthma attack 
measurements, designs, and analysis procedures.50,64 The large sample size and multiple study 
sites make Engelkes et al.’s study results more reliable and generalizable compared to that of 
Sanya et al.64 Therefore, these observations show that our findings have to be taken with 
caution. 
5.4.12. Knowledge of asthma allergens  
The Chi-square statistic revealed no significant association between lack of knowledge on 
asthma allergens and acute asthma attack (p = 0.462). This is in line with the results of the 
logistic regression (OR 0.79, 95% CI: 0.60 to 1.03; p = 0.086). Thus, lack of knowledge on 
asthma allergens was not a significant factor associated with acute asthma attack in these 
patients. This conclusion has been reported in many other studies, namely by Janssens et al. 
in Belgium; Sanya et al. in Uganda; and Geyser et al. in South Africa.23,49,68 In our study the 
participants had better knowledge about asthma allergens. However, knowledge needs to be 
put into practice in order to benefit from it. Thus, a possible explanation is that these patients 
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are not practising their knowledge on asthma triggers. However, other studies have found 
contradictory results in the sense that there was a significant association between knowledge 
of asthma allergen and acute asthma attack (all p < 0.05).14,31,47  
5.4.13. Stress or anxiety  
The Chi-square statistic revealed no significant association between suffering from stress or 
anxiety and acute asthma attack (p = 0.590). This is in line with the results of the logistic 
regression (OR 1.42, 95% CI: 0.54 to 3.76; p = 0.476). Thus, stress or anxiety was not a 
significant factor associated with acute asthma attack in these patients. This was similar to the 
study by Sanya et al. in Uganda, which found that anxiety (OR 0.677, 95% CI: 0.197 to 
2.326; p = 0.535) and stress (OR 0.580, 95% CI: 0.231 to 1.460; p = 0.247) were not 
significant factors associated with acute asthma attack.23 Geyser et al. in Pretoria also arrived 
at the same conclusion (anxiety: OR 0.95, 95% CI: 0.42 to 2.11; p = 0.89) and stress (OR 
1.05, 95% CI: 0.51 to 2.13; p = 0.90).49 This was in contrast with the findings by Kolbe et al. 
in New Zealand.70 The significant difference in findings between these studies may be 
explained by the higher prevalence of stress or anxiety in developed countries compared to 
developing countries.10,71 Other explanations could be that stress or anxiety was not 
objectively assessed in the study, and reliance was instead placed on patients’ self-report 
assessments. The study found a relatively small proportion of patients with stress or anxiety. 
It is possible that this small number of asthma patients with stress or anxiety in the study 
could not give sufficient statistical power to detect the difference between stress or anxiety 
and asthma exacerbation in these patients.1,64 Thus, these observations indicate that our 
conclusion needs to be taken with caution. 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
6.1. Conclusions 
The study has gained valuable information. Firstly, the study documents a relatively low 
proportion of acute asthma attack at the BGH ED. Secondly, the study shows that the 
majority of patients presented at the BGH ED with moderate acute asthma attack. However, 
the relatively significant proportion of patients with severe acute asthma attack reported in 
this study remains of concern. Thirdly, the study shows that the majority of patients with 
acute asthma attack who presented at the BGH ED were black, young adult males, completed 
secondary school, were employed, and had an occupation, live in a modern (urban) type of 
house, and were adherent to asthma treatment. Fourthly, this study demonstrated that lower 
level of education is a significant factor associated with acute asthma attack presentation. 
Lastly, the study shows that active and/or passive cigarette smoking is a potential associated 
trigger for acute asthma attack. This is a modifiable or avoidable trigger and warrants prompt 
interventions. 
6.2. Source of bias 
Firstly, the study was done during a short period of four months. Secondly, the questions that 
assessed patients’ knowledge of asthma allergens did not contain any non-asthma allergens. 
These two factors might be regarded as potential sources of bias. 
6.3. Potential strengths of the study 
The study does have strengths. Firstly, it was a prospective study and therefore there was the 
opportunity to collect all the information that was required for the study analysis. Secondly, 
the study was powered, with the help of a statistician, prior to being conducted, to ensure that 
a sufficient number of patients was recruited in order to allow accurate statistical analysis. 
Finally, this study has relevance to Family Medicine and its practice in South Africa, as 
asthma has a significant morbidity and mortality, especially in South Africa, a developing 
country with a developing PHC system facing resource constraints. 
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6.4. Limitations of the study 
The study does have some limitations. Firstly, the study was conducted at one site, in one 
area of the country and in a public, district hospital setting only. As a result the findings may 
not be generalizable to other geographical areas of South Africa and other settings and levels 
of care, including private hospitals and secondary- and tertiary-care hospitals. Secondly, 
variables like anxiety, stress, adherence to asthma treatment and acute respiratory infection 
were not objectively assessed in the study, and reliance was instead placed on patients’ self-
report assessments. Thirdly, the definition of passive cigarette smoking in the context of this 
study was limited to cigarettes smoked by the patient’s household.  
Lastly, patients unable to perform PEF assessment were excluded from the study. It is 
possible that there were cases of imminent respiratory arrest asthma exacerbations among the 
excluded patients. This category of asthma exacerbation was not part of the study. However, 
there were only 3.20% of patients excluded from the study because of not being able to 
perform a PEF assessment. Therefore, their inclusion in the study would not significantly 
affect the overall conclusions.  
6.5. Recommendations 
The results of the study will be discussed by the researcher with the BGH staff, including 
those in the ED. With regard to the main findings from the study the following priority 
improvements are recommended: 
1. Although the proportion of acute asthma attacks at the BGH ED documented in the study 
was relatively low, HCPs still need to be committed to decreasing significantly the proportion 
of this condition at the BGH when taking into account the overall higher morbidity and 
mortality related to asthma. Also, the lowering of acute asthma presentation rates will 
ultimately curb the expenditure associated with asthma care. 
2. Although in the study factors like age, gender, race, employment and occupation status, 
type of housing, knowledge of asthma allergens, URTI, not adhering to asthma treatment, 
medication-related asthma, and stress and anxiety were not identified as potential factors 
and/or triggers associated with acute asthma attack presentation, effort should be made 
nationally at all levels of care to educate patients on avoidance of these factors and/or 
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triggers, when applicable, as other many studies have demonstrated their strong associations 
with asthma exacerbation. 
3. Vigorous asthma education programmes in relation to passive and/or active cigarette 
smoking should be promulgated by the BGH staff. This will ultimately optimize patient care 
and improve health outcomes. 
4. It would seem, based on the current investigation, that further studies exploring the 
proportion, severity, socio-demographic profile and triggers associated with acute asthma 
attack presentation would be useful, particularly in our setting in South Africa. 
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7. APPENDICES 
Appendix A: Assessment of severity in acute asthma as per WGSATS9  
 
Observation Mild Moderate Severe IRA 
PEF AIB >80% of best 
predicted 
60 - 80% of best predicted < 60% of best predicted < 100 l/min 
Breathless posture Walk or can lie down When talking prefer to sit At rest hunched forward Exhaustion 
Talk in Sentences Phrases Words  
Alertness May be agitated Agitated Agitated Drowsy or 
confused 
Respiratory rate Increased Increased Often > 30 breaths/ min  
Accessory muscles Usually not Usually Usually Thoraco-abdominal 
movements 
Wheeze Moderate Loud Usually loud Absent: silent chest 
Pulse < 100 beats/ min 100 – 120 beats/ min  120 beats/ min Bradycardia 
Pa 02 on air Normal  8 KPa or > 60 
mmHg 
< 8 KPa or < 60 mm 
Hg or may be cyanosed 
Cyanosis 
Sa O2 on air  95% 91 – 95% < 90%  
Pa Co2 < 45 mm Hg < 45 mmHg  45 mmHg  
IRA: Imminent respiratory arrest, Pa Co2: arterial blood carbon dioxide pressure, Pa O2: Arterial blood oxygen pressure, PEF AIB: Peak 
expiratory flow after initial bronchodilator, Sa O2: Arterial blood oxygen saturation. The presence of several parameters, but not necessarily 
all, indicates the general classification of the exacerbation 
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Appendix B: Study questionnaire 
Part I: Socio-demographic characteristics 
1. How old are you, in years? 
2. Gender: 
1. Male 
2. Female  
3. Race:          
1. White 
2. Black 
3. Indian 
4. Coloured  
4. What is your employment status?   
1. Employed 
2. Non-employed                  
5. What is your occupation? 
1.  No occupation  
2. Occupation (specify):  
6.     What is your level of education? 
1. No school 
2. Primary school 
3. Secondary school 
4. Tertiary school (or post-matric schooling): 
 
7. What type of house are you living in? 
3. Reconstruction and development programme (RDP)   
4. Informal settlement 
5. Squatter camp     
6. Hostel      
7. Flat       
56  
 
8. Townhouse     
9. Other type of house (specify):  
8. Which of the following areas is your place of residence?  
1. Urban  
2. Semi-urban  
3. Rural  
Part II: Acute asthma severity assessment 
 
9. Assessment of acute asthma severity:  
3. Mild 
4. Moderate 
5. Severe 
NB: Please use the WGSATS guidelines attached to assess the severity of asthma 
exacerbation.   
 
Part III: Asthma triggers 
Section 1: Acute infection 
10. Do you suffer from or have very recently had any of the following illnesses? 
Upper respiratory infections:  
1. Flu 
2. Sinus infection 
3. Ear infection 
4. Tonsillitis 
5. Laryngitis 
6. Pharyngitis 
7. Other (specify): 
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        Lower respiratory infections: 
1. Community-acquired pneumonia 
2. Bronchitis 
3. Bronchopneumonia 
4. Other (specify): 
Section 2: Use of medication  
11. Patient is on or has recently used one of the following medications (this will be 
obtained from the patient’s medical records): 
1. Aspirin 
2. Voltaren or Diclofenac 
3. Brufen 
4. Atenolol 
5. Propanolol 
6. Other medication containing aspirin, ibuprofen, or other NSAIDs (specify): 
 
Section 3: Adherence to asthma treatment 
12. Do you use your asthma medication every time as prescribed? 
1. Yes 
2. No 
3. Not sure 
 
Section 4: Asthma allergens 
13. Which of the following are asthma triggers? (Yes, No, or Not sure) 
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Allergen type Yes     No  Not sure 
Cigarette smoke 
 
  
Cold weather 
 
  
Feathers 
 
  
Dust at home or street 
 
  
Chemicals like paint, detergents, soap 
 
  
Spray from deodorant, perfume and air 
fresher  
  
Seeds from weed or grass 
 
  
Pollen 
 
  
Cockroaches 
 
  
Fruits like peanut and mango 
 
  
Smoke from coal, fire, wood and 
paraffin stoves  
  
Red wine 
 
  
Cat 
 
  
Yellow/orange flavoured/coloured food 
 
  
 
 
Section 5: Other trigger factors 
       17. a. Do you smoke? 
1. Yes 
2. No 
 
      17. b. If yes, how many cigarettes per day?  
1. < 5 
2. 5-10 
3. > 10 
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18. Does anyone smoke cigarettes at home? 
4. Yes 
5. No 
19. Are you sick from or have you recently had from the following illnesses: 
 
1. Stress 
2. Anxiety 
 
 
                                                                              PIN:……………… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60  
 
Appendix C: BGH ED staff information sheet 
 
Dear colleagues 
Good day! I am Dr Dalton Kabundji. I am currently a student in the MMed Family 
Medicine in the Department of Family Medicine, Faculty of Heath Sciences, University of 
the Witwatersrand. I am doing a project for my research report, and am inviting you to 
volunteer for this research study. 
Asthma is a major public health problem worldwide, generates significant healthcare costs 
and has high morbidity and mortality rates. Many preventable trigger factors have been 
reported to cause patients to have poor asthma control status, thus leading to frequent ED 
visits and subsequent hospital admissions, and acute asthma attack is preventable with 
optimal control of them. Therefore understanding the trigger factors leading to asthma-related 
ED visits is important in controlling chronic asthma. This will also allow the development of 
specific intervention strategies to reduce the incidence of serious adverse events, therefore 
improving health outcomes.  
The aim of the study is to determine the severity and associated triggers of acute asthma 
attack in patients presenting at the BGH ED. I will request you to assess the patient’s acute 
asthma severity as per WGSATS recommendation. After the patient is managed and 
stabilized by you, I will attend to him/her and request voluntary participation in the study. I 
will take approximately fifteen minutes with the patient. If he/she agrees I will proceed as 
follows: 
 I will confirm that the patient fulfils the study’s inclusion criteria by asking him/her 
questions about his/her conditions and details about his/her symptoms. 
 Following this I will collect all the relevant information required for the study. 
 In order to protect patients’ confidentiality, when recording details patients will be 
given a unique PIN. The PIN will be known only to the researcher and the supervisors 
of the study. 
 Finally, I will analyse the data to determine the severity and associated triggers of 
acute asthma attack in these patients. 
I would also like to state that none of your personal information will be recorded for this 
study. 
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The study will benefit participants for the future. This study will identify triggers of acute 
asthma attack in patients and deficiencies in the healthcare system. Therefore the hospital 
management will develop specific intervention strategies of addressing them, thus reducing 
the incidence of serious adverse events and improving health outcomes. There is no financial 
gain in participating in the study. 
 Thank you so much. 
 
Dr Dalton M Kabundji 
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Appendix D: Patient information sheet and consent form 
 
Dear Sir/Madam 
Good day! I am Dr Dalton Kabundji. I am currently a student in the Department of Family 
Medicine, Faculty of Heath Sciences, University of the Witwatersrand. I am doing a project 
for my research report, and am inviting you to volunteer for this research study. 
Asthma is a major public health problem worldwide, generates significant healthcare costs 
and has high morbidity and mortality rates. Many preventable trigger factors have been 
reported to cause patients to have poor asthma control status, thus leading to frequent ED 
visits and subsequent hospital admissions, and acute asthma attack is preventable with 
optimal control of them. Therefore understanding the trigger factors leading to asthma-related 
ED visits is important in controlling chronic asthma. This will also allow the development of 
specific intervention strategies to reduce the incidence of serious adverse events, therefore 
improving health outcomes.  
The aim of the study is to determine the severity of your disease and associated triggers that 
caused you to have asthma attack today. Please understand that your decision to participate in 
this research study is entirely voluntary and you are free to decline to join or withdraw your 
consent at any time, without consequence. I will take approximately fifteen minutes with you, 
and the study will be completed in twelve months. If you agree I will proceed as follows: 
 I will confirm that you fulfil the study’s inclusion criteria by asking you questions 
about your condition and details about your symptoms.  
 In order to protect patients’ confidentiality, when recording details, you will be given 
a PIN. The PIN will be known only to the researcher and the supervisors of the study. 
 Following this I will collect all other relevant information for the study such as your 
age and gender, race, level of education, occupation and smoking status, type of house 
in which you live, your knowledge about asthma triggers, the use of some painkillers 
and antihypertensive medication by you, and if you adhere to your prescribed asthma 
treatment. 
 Finally, I will analyse all relevant data to determine the reasons causing you to have 
asthma attack.  
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 I will need you to sign consent at the outset, and will retain a signed copy. Any 
personal information of yours that I collect during the course of this study will be kept 
strictly confidential. 
The study will benefit you in the future. This study will identify triggers of acute asthma 
attack in patients and deficiencies in the healthcare system. Therefore the hospital 
management will develop specific intervention strategies to address them, thus reducing the 
incidence of serious adverse events and improving health outcomes. There is no financial 
gain in participating in the study. 
If you want any information regarding your rights as a research participant, or complaints 
regarding this research study, you may contact the Chairperson of the University of the 
Witwatersrand, Human Research Ethics Committee (HREC), which is an independent 
committee, established to help protect the rights of research participants, at (011) 717-2230/1. 
Also, in case of future concerns/questions regarding the study, you might contact me directly 
at my cell phone number: 0734494682 or email: jdmulombe@yahoo.fr 
I,                                                                                (participant), fully understand the research 
study aim, that my participation is entirely voluntary and that I may withdraw from the study 
at any time, without any consequences.  
Thank you so much. 
Patient’s signature:  
I,                                                      (researcher), confirm that I have explained the research 
process to the participant, and that I will adhere to the generally accepted ethical norms of 
research. 
Researcher’s signature:                                   Witness’s signature:   
Date:            /         /2015. 
PIN: _________                               
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Appendix E: Wits Human Research Ethics Committee (Medical) clearance 
certificate  
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Appendix F: Ekurhuleni Health District Research Committee clearance 
certificate 
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Appendix G: Patient identification sheet 
 
1. Surname and initials: 
2. File number: 
3. PIN: 
 
Dalton Kabundji 
Date:      /       /2015                                Signature: 
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Appendix H: Wits Faculty of Health Sciences’ Higher Degree Committee 
approval of the research project title 
 
 
 
 
 
68  
 
Appendix I: Research report English editing certificate 
PROFESSOR CRAIG MACKENZIE – EDITOR 
Professor of English, University of Johannesburg 
BA (Hons), MA (Natal), PhD (Rhodes) 
 
  ____________________________________________________ 
 
26 June 2016 
 
To Whom It May Concern: 
 
This is to confirm that I edited “Severity and Associated Triggers for Acute Asthma Attack in 
Patients Presenting to the Emergency Department of the Bertha Gxowa Hospital”, by Dalton 
Mulombe Kabundji. 
 
All errors identified were corrected electronically and marked with the ‘track changes’ 
function.  
 
The document was edited in accordance with the latest conventions of style and expression. 
 
 
 
Sincerely 
 
 
 
Prof. C. H. MacKenzie 
 
 
 
 
 
 
 
 
 
 
Email: craigm@uj.ac.za; tel: w/ 27-11-559-2553; cell: 083-969-3029; fax: 27-11-559-3615 
 
 
 
69  
 
7. REFERENCES 
 
1. Farlex. The free dictionary. From http://www.thefreedictionary.com/ (Last accessed: 
20 June 2016).  
2. Lalloo UG, Ainslie GM, Wong M, Abdool-Gaffar S, Irusen E, Mash R, et al. 
Guidelines for the management of chronic asthma in adolescents and adults. SA Fam 
Pract 2007; 49(5): 19-31. 
3. Rowe BH, Sevcik W, Villa-Roel C. Management of severe acute asthma in the 
emergency department. Curr Opin Crit Care 2011; 17(4): 334-41.  
4. WHO. Bronchial asthma. Fact Sheet n 206. 
From www.who.int/mediacentre/factsheets/fs2006/ (Last accessed: 14 October 2015). 
 
5. Tintinalli JT, Kelen GD, Stapczynski JS. Emergency medicine: a comprehensive 
study guide. 6th ed. New-York: McGraw-Hill and American College of Emergency 
Physicians; 2004. p. 467-75.  
 
6. Ehrlich RI, Jithoo A. Chronic respiratory infections in South Africa. In Steyn K (ed). 
Chronic diseases of lifestyle in South Africa since 1995-2005. Cape Town: Medical 
Research Council of South Africa; 2006. p. 368-71. 
7. Zak HJ, Lalloo UG. Acute asthma treatment guidelines: reducing mortality and 
morbidity in South Africa. SAMJ 2013; 103(3): 159-60. 
8. Adeloye D, Chan KY, Rudan I, Campbell H. An estimate of asthma prevalence in 
Africa: a systematic analysis. Croat Med J 2013; 54: 519-31. 
9. Lalloo UG, Ainslie GM, Abdool-Gaffar MS, Awotedu AA, Feldman C, Greenblatt M, 
et al. Guideline for the management of acute asthma in adults: 2013 update. SAMJ 
2013; 103(3): 189-98.  
10. Longo DL, Fauci AS, Kasper DL, Jameson JL, Hauser SL, Loscalzo J. Harrison’s 
principles of internal medicine. 18th ed. New-York: McGraw-Hill; 2012. p. 2102 – 15. 
70  
 
11. Al-Jahdali H, Anwar A, Al-Harbi A, Baharoon S, Halwani R, Al-shimemeni A. Factors 
associated with patient visits to the emergency department for asthma therapy. BMC 
Pulm Med 2012; 12:80-7.  
12. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of 
the key components. Thorax 2004; 59: 94-99.  
13. Goksel O, Celik GE, Erkekol FO, Gullu E, Mungam D, Misirligil Z. Triggers in adult 
asthma: are patients aware of triggers and doing right? Allergl Immunopath (Madr) 
2009; 37(3): 122-8. 
14. Westerman DE, Bateman ED, Alexander MG, Benatar SR. The magnitude of the 
asthma problem in Cape Town. SAMJ 1978; 53: 574-77.  
15. Van der Merwe L, De Klerk A, Kidd M, Bardin PG, Van Schalkwyk EM. Case-control 
study of severe life-threatening asthma (SLTA) in a developing community. Thorax 
2006; 61: 756-60.  
16. American Academy of Allergy Asthma and Immunology (AAAAI). From: http:// 
www.aaaai.org/about-the-aaaai/newsroom/asthma-statistic.asp (Last access: 27 
September 2015). 
17. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults. CHEST 2004; 125 (3): 
1081-102.  
18. Kirenga JB, Okot-Nwang M. The proportion of asthma and patterns of asthma 
medications prescriptions among adult patients in the chest, accident and emergency 
units of a tertiary health care facility in Uganda. Afri Health Sci 2012; 12 (1): 48-53.  
19. Watase H, Hagiwara Y, Chiba T, Camargo C, Hasegawa K.  Multicentre 
observational study of adults with asthma exacerbations: who are the frequent users of 
the emergency department in Japan? BMJ 2015; 5: 1-7. 
20. BTS/SIGN Asthma Guideline 2014 British Thoracic Society. From: https://www.brit-
thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-
guideline-2014/ (Last accessed: 10 June 2015). 
21. Dankner R, Olmer L, Ziv A, Bentancur AG. A simplified severity score for acute 
asthma exacerbation. J Asthma 2013; 50(8): 871-76.  
71  
 
22. Refaat S, Aref H. Acute asthma in emergency department, prevalence of respiratory 
and non-respiratory symptoms. The ESCT 2014; 63: 777-6. 
23. Sanya RE, Kirenga JB, Worodria W, Okot-Nwang M. Risk factors for asthma 
exacerbation in patients presenting to an emergency unit of a national referral hospital 
in Kampala, Uganda. Afri Health Sci 2014; 14(3): 1-9.  
24. Weiss KB, Gergen PT, Hodgson TA. An economic evaluation of asthma in the United 
States. N Engl J Med 1992; 326(13): 862-6.  
25. Eisner MD, Katz PP, Yelin EH, Shiboski S, Blanc PD. Risk factors for hospitalization 
among adults with asthma: the influence of socio-demographic factors and asthma 
severity. Respir Res 2001; 2 (1): 53-60.  
26. Bavbek S, Celik G, Demirel YS, Misirligil Z. Risk factors associated with 
hospitalizations for asthma attacks in Turkey. Allergy Asthma Proc 2003; 24 (6): 437-
42.  
27. Fernandes AGO, Souza-Machado C, Coelho RCP, Franco PA, Esquivel RM, Souza-
Machado A, et al. Risk factors for death in patients with severe asthma. J Bras 
Pneumol 2014; 40(4): 364-72.  
28. Kynyk JA, Mastronarde JG, McLallister JW. Asthma, the sex difference. Curr Opin 
Pulm Med 2011; 17(1): 6-11.  
29. Ikeue T, Nakagawa A, Furuta K, Morita K, Tajiri T, Maniwa K, et al. The prevalence 
of cigarette smoking among asthmatic adults and association of smoking with 
emergency department visits. Nihon Kokyuki Gasshi 2010; 48(2): 99-103.  
30. Boudreau ED, Emond SD, Clark S, Camargo CA. Acute asthma among adults 
presenting to the emergency department: the role of race/ethnicity and socioeconomic 
status. CHEST 2003; 124(3): 803-812.  
31. Green R, Davis G, Price D. Perceptions, impact and management of asthma in South 
Africa: a patient questionnaire study. Prim Care Resp J 2008; 17(4): 212-16. 
32. Schwenkglenks M, Anderhub H, Szucs TD. Costs of asthma in a cohort of Swiss 
adults: associations with exacerbation status and severity. Value Health 2003; 6(1); 
75-83.  
72  
 
33. Brandao HV, Cruz CS, Pinheiro MC, Costa EA, Guimaraes A, Souza-Machado A, et 
al. Risk factors for emergency room visits due to asthma exacerbations in patients 
enrolled in a program for the control of asthma and allergic rhinitis in Feira de 
Santana, Brazil. J Bras Pneumol 2009; 35(12): 1168-73. 
34. Tang S, Drake P. Hospital admission and mortality differentials of asthma between 
urban and rural populations in New South Wales. Aust J Rural Health 1999; 7:18-22. 
35. Higgins BG, Britton JR. Geographical and social class effects on asthma mortality in 
England and Wales. Respir Med 1995; 89: 341-6.  
36. Stapleton M, Howard-Thompson A, George C, Hoover R, Self TH. Smoking and 
asthma. J Am Board Fam Med 2011; 24: 313-22. 
37.  Diaz-Sanchez D, Rumold R, Gong H. Challenge with environmental tobacco smoke 
exacerbates allergic airway disease in human beings. J Allergy Clin Immunol 2006; 
118: 441-6. 
38. Patel SN, Tsai CL, Boudreaux ED, Kilgannon JH, Sullivan AF, Blumenthal SD, et al. 
Multicenter study of cigarette smoking patients presenting to the emergency 
department with acute asthma. Ann Allergy Asthma Immunol 2009; 103(2): 121-7.  
39. Morkjaroenpong V, Rand CS, Buts AM, Huss K, Eggleston P, Malveaux FJ, et al. 
Environmental tobacco smoke exposure and nocturnal symptoms among inner-city 
children with asthma. J Allergy Clin Immunol 2002; 110: 147-53. 
40. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir 
J 2004; 24: 822-33. 
41. Jindal SK, Gupta D. Role of active smoking in asthma in adults. Indian J Med Res 
2004; 443-53. 
42. Wark PA, Tooze M, Powell H, Parsons K. Viral and bacterial infection in acute 
asthma and chronic obstructive pulmonary disease increases the risk of readmission. 
Respirology 2013; 18(6): 996-1002.  
43. Osur SL. Viral respiratory infections in association with asthma and sinusitis: a 
review. Ann Allergy Asthma Immunol 2002; 89 (6): 553-60.  
73  
 
44. Johnston SL. Viruses and asthma. Allergy 1998; 53(10): 922-32.  
45. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma 
in adults. BMJ 1993; 307: 982-86. 
46. Gillissen A. Patient’s adherence in asthma. J Physiol Pharmacol 2007; 58 Suppl 5 
(1): 205-22.  
47. Taylor DMcD, Auble TE, Calhour WJ, Mosesso VN. Current outpatient management 
of asthma shows poor compliance with international consensus guidelines. CHEST 
1999; 116 (6): 1638-45.  
48. Braido F. Failure in asthma control: reasons and consequences. Scientifica 2013; 
2013: 1-15. 
49. Geyser MM, Rheeder P. Risk factors precipitating exacerbations in adult asthma 
patients presenting at Kalafong Hospital, Pretoria. SA Fam Pract 2008; 50(4): 67-74.  
50. Engelkes M, Janssens HM, De Jongste J, Sturkenboom MCJM, Verhamme KMC. 
Medication adherence and the risk of severe asthma exacerbations: a systematic 
review. Eur Respir J 2015; 45(2): 396-407.  
51. Sundberg R, Toren K, Franklin KA, Gislason T, Omenaas E, Svanes C, et al. Asthma 
in men and women: treatment adherence, anxiety, and quality of sleep. Resp Med 
2010; 337-44. 
52. Manteuffel M, Williams S, Chen M, Verbrugge RR, Pittman DG, Steinkellner A. 
Influence of patient sex and gender on medication use, adherence, and prescribing 
alignment with guidelines. J Women Health 2014; 23(2): 112-19. 
53. Dinwiddie R, Muller WG. Adolescent treatment compliance in asthma. J R Soc Med 
2002; 95: 68-71. 
54. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, et al. The 
role of cockroach allergy and exposure to cockroach allergen in causing morbidity 
among inner-city children with asthma. N Engl J Med 1997; 336: 1356-63. 
55. Rosas I, McCartney HA, Payne RW, Calderon C, Lacey J, Chapela R, et al. Analysis 
of the relationships between environmental factors (acroallergens, airpollution, and 
74  
 
weather) and asthma emergency admissions to a hospital in Mexico City. Allergy 
1998; 58: 394-401. 
56. Lee PY, Khoo EM. How well were asthmatic patients educated about their asthma: a 
study of the emergency department. Asia-Pacific J public Health 2004; 16: 45-9. 
57. Hasegawa K, Brenner BE, Clark S, Camargo CA. Emergency department visits for 
acute asthma by adults who run out of their inhaled medications. Allergy asthma Proc 
2014; 35(3): e42-e50. 
58. Schatz M, Clark S, Camargo CAJ. Sex differences in the presentation and course of 
asthma hospitalizations. CHEST 2006; 129 (1): 50-5.  
59. Pearson MG, Ryland I, Harrison BDW. National audit of acute severe asthma in 
adults admitted to hospital. Qual Health Care 1995; 4: 24-30.  
60. WHO 2016. Global health observatory data repository: life expectancy data by 
countries. From: http://apps.who.int/gho/data/node.main.688?lang=en (Last accessed: 
18 June 2016). 
61. Bellamy D, Collins JV. Acute asthma in adults. Thorax 1979; 34: 36-39.  
62. El-Ekiaby A, Brianas L, Skowronski ME, Coreno AJ, Galan G, Frank J, et al. Impact 
of race on the severity of acute episode of asthma and adrenergic responsiveness. Am 
J Respir Crit Care Med 2006; 174: 508-13. 
63. Omachi TA, Iribarren C, Sarkar U, Tolstykh I, Yelin EH, Katz PP, et al. Risk factors 
for death among adults with severe asthma. Ann Allergy Asthma Immunol 2008; 101 
(2): 130-136. 
64. Machin D, Campbell MJ, Walters SJ. Medical statistics. 4th ed. Sheffield: John Wiley 
& Sons; 2007. p. 108-274. 
65. Nogueira KT, Silva JRL, Lopes CS. Quality of life of asthmatic adolescents: 
assessment of asthma severity, comorbidity, and life style. J Pediatr (Rio J) 2009; 85 
(6): 523-530. 
75  
 
66. Radon K, Busching K, Heinrich J, Wichmann HE, Jorres RA, Magnussen H, et al. 
Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults. 
CHEST 2001; 122: 1086-90.  
67. Chetty N. Asthma exacerbations: a review. Current Allergy & Immunology 2009; 
22(2): 75-78.  
68.  Janssens T, Ritzt T. Perceived triggers of asthma: key to symptom perception and 
management. Clin Exp Allergy 2013; 43(9): 1000-8. 
69. Stepphun H, Langen U, Scheidt-Nave C, Keil T. Major comorbid conditions in 
asthma and association with asthma-related hospitalization and emergency department 
admissions in adults: results from the German national health telephone interview 
survey GEDA 2010. BMC pulm Med 2013; 13:46-55. 
70. Kolbe J, Fergusson W, Vamos M, Garrett J. Case-control study of severe life 
threatening asthma (SLTA) in adults: psychological factors. Thorax 2002; 57: 317-
322.  
71. Murtagh J. Murtagh’s general practice. 5th ed. Australia: McGraw-Hill; 2010. p. 568-
78. 
72. South African Department of Health 2002. A district hospital service package for 
South Africa. From: www.kznhealth.gov.za/norms.pdf (Last accessed: 18 June 2016). 
73. Raosoft Software. From: http://www.raosoft.com/samplesize.html (Last accessed: 25 
June 2015). 
 
 
 
 
 
  
 
 
